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Abstract: This paper provides a comprehensive overview of nanofibrous structures for tissue
engineering purposes and the role of non-thermal plasma technology (NTP) within this field.
Special attention is first given to nanofiber fabrication strategies, including thermally-induced phase
separation, molecular self-assembly, and electrospinning, highlighting their strengths, weaknesses,
and potentials. The review then continues to discuss the biodegradable polyesters typically employed
for nanofiber fabrication, while the primary focus lies on their applicability and limitations. From
thereon, the reader is introduced to the concept of NTP and its application in plasma-assisted surface
modification of nanofibrous scaffolds. The final part of the review discusses the available literature on
NTP-modified nanofibers looking at the impact of plasma activation and polymerization treatments
on nanofiber wettability, surface chemistry, cell adhesion/proliferation and protein grafting. As such,
this review provides a complete introduction into NTP-modified nanofibers, while aiming to address
the current unexplored potentials left within the field.
Keywords: electrospun nanofibers; non-thermal plasma treatment; tissue engineering
1. Introduction
Injury, trauma or disease can lead to degeneration or damage of tissues in the human body,
which requires treatments to initiate their repair and regeneration procedure [1]. Conventionally, the
condition is treated by transplanting tissue from one point to another point of the same body (an
autograft) or from one body site to another body site of a different patient (a transplant or allograft) [2,3].
Although these treatments have been revolutionary and lifesaving, both techniques involve some
major issues. The retrieval of autograft tissue is expensive, painful and often correlated with morbidity
of the donor site as a result of infections and hematoma. In the same way, allografts also have serious
limitations because of their limited supply and the possibility of disease transmission from donor to
patient and tissue rejection by the patient’s immune system [4,5]. The abovementioned problems have
led to the emergence of tissue engineering (TE), which aims to repair damaged tissues through tissue
regeneration rather than replacing them [6,7].
TE is an interdisciplinary discipline combining the principles of engineering and life sciences
to develop biological substitutes that restore, maintain or improve the functions of tissues [1,8]. TE
encompasses three major approaches: (1) transplantation of cells isolated from a healthy part to
an injured tissue, (2) injection of factors that initiate/induce tissue regeneration like growth factors,
Nanomaterials 2020, 10, 119; doi:10.3390/nano10010119 www.mdpi.com/journal/nanomaterials
Nanomaterials 2020, 10, 119 2 of 63
differentiation factors, polysaccharides, and peptides to a targeted site; and (3) seeding of cells in
combination with growth factors on a three-dimensional (3D) matrix, referred to as “a scaffold”, which
acts as a temporary framework on which cells can adhere, grow and differentiate in vitro prior to
implantation in vivo [1,9–11] as schematically presented in Figure 1. Among these current strategies,
scaffold-based TE has become the most commonly used approach and will consequently be the main
focus of this review paper.
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The design of a scaffold prior to exposure to cells is f ital i rtance. Although the favorable
elements of an engineered scaffold can slightly differ fro the tissue characteristics of the target, there
are several scaffold requirements which have been identified as crucial:
(1) The scaffold needs to be bio-compatible so that it integrates well with the host body without
eliciting any mutagenic, carcinogenic or cytotoxic behavior which can cause a major inflammatory
response [12–14].
(2) The scaffold must possess the mechanical properties necessary to temporarily offer structural
support until new issue ha formed [15–17].
(3) The scaffold must possess surface properties that allow attachment, migration, proliferation, and
differentiation of cells [18].
(4) The scaffold must be biodegradable in a way that additional surgery is not required for implant
removal. Ideally, the degradation rate should match the rate of new tissue formation [19,20].
(5) The porosity of the engineered scaffold and the scaffold’s surface-volume ratio should be high
to enable cell attachment, to provide in-growth sites for cells to adhere and proliferate and to
facilitate nutrients exc ange upon in vitr or in vivo cultu e [21].
(6) The scaffold should simulate the native extracellular matrix (ECM) both in structure s well as in
biological function. The ECM is known to have a fibrillar structure: collagen, the most abundant
ECM protein in the human body, is made of continuous fibers with diameters that vary in the
ranges of 50 to 500 nm [22,23].
TE scaffolds can be fabricated using multiple methods including freeze-drying [24], solvent
casting [25], particulate leaching [26], gas foaming [27], rapid prototyping [28,29]. These TE scaffold
fabrication methods have already been widely described in multiple review papers and will therefore
not be discussed in this paper [24,30–32]. All of the bove-mentioned methods have their intrinsic
advantages and disadvantages, but m st of them are incapable of producing ECM mimicking
nanofibrous scaffolds. To cope with this issue, researchers have put muc effort into developing
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nanofibrous TE scaffolds, which can mimic the fibrous structure of natural ECM. Currently, there are
three different techniques available for the generation of nanofibrous scaffolds: phase separation [33,34],
molecular self-assembly [35,36], and electrospinning [37,38]. An introduction to each of these
fabrication techniques will be given in the first part of this review paper. Of the mentioned techniques,
electrospinning is the most widely studied nanofibrous scaffold fabrication method as evidenced by
a survey of publications published worldwide since 1994 (see Figure 2, comparing the frequently
used methods to produce nanofibers for tissue engineering applications based on a search in Web
of Science), and also seems to hold the most promising results for TE applications. On the contrary,
nanofibers synthesized by self-assembly and phase separation have had relatively limited studies that
explored their application as scaffolds for TE. As such, this review paper will particularly focus on
electrospinning as a nanofibrous TE scaffold fabrication method.
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most common used nanofibrous tissue engineering (TE) scaffold fabrication technique.
While electrospinning is capable of constructing nanofibrous TE scaffolds, the ultimate success of
these scaffolds is of course also strongly deter ined by the aterial selection. Indeed, the aterial
choice influences important scaffold characteristics such as mechanical strength, biocompatibility,
and degradation kinetics. Although electrospun fibers can be generated from different material
classes including polymers [39], ceramics [40] and inorganics [41], polymers are the primary class
of materials for designing electrospun scaffolds thanks to their design flexibility and their excellent
bulk properties. As a result, electrospun TE scaffolds have been mostly fabricated from a multitude
of both synthetic and natural polymers [42,43]. Natural polymers, owing to their biodegradability
and excellent bioactive properties, have attracted significant attention in TE applications. Natural
polymers are either compounds of the native ECM or polymers extracted from other biological
systems [44,45]. Unfortunately, the applicability of these natural polymers as such is often hindered
due to low availability, batch-to-batch variation, weak mechanical properties and rapid degradation
in aqueous conditions [46]. In the last few decades, synthetic polymers have been developed as
alternatives to natural polymers due to their improved performance, low cost, ease of production
and more reproducible properties [47,48]. In the field of electrospun TE scaffolds, mainly synthetic
biodegradable aliphatic polyesters are considered to be excellent scaffold candidates, as their physical
and che ical properties, such as mechanical strength and degradation rate, can be tailore to meet
specific requir ment of TE scaff l [49,50]. An overview of biodegradabl polyesters fr qu ntly
used for the fabrication of electrospun TE scaffolds together ith their most important properties will,
therefore, be given in the second part of this review paper. This overview will allow the reader to
obtain a b sic u derstanding of the different biodegradable polyesters and will enable him/her to select
the most appropriate synthetic polymer for a particular TE application.
2. Fabrication of Nanofibrous TE Scaffolds
As mentioned in the introduction, three methods are currently available for the fabricatio of
nanofibrous TE scaffolds: (1) phase s paration, (2) molecular self-assembly, and (3) electrospinning.
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Each of these methods will be described in detail in the following paragraphs. As electrospinning is
by far the most established method (see Figure 2), most attention will be paid to this nanofibrous TE
scaffold fabrication technique.
2.1. Thermally-Induced Phase Separation
An interesting method used to manufacture nanofibrous TE scaffolds is phase separation. A phase
separation process can be initiated either thermally or by a non-solvent and has already been widely
used for the fabrication of porous membranes or foams for filtration and separation methods [51,52].
Non-solvent induced phase separation typically results in matrices with a heterogeneous pore structure,
which is not desirable for TE scaffolds as these generally require a uniform pore structure [53,54].
As such, only thermally-induced phase separation will be described in this paper as this technique is
capable of producing homogeneous porous scaffolds [55,56].
When a homogenous polymer solution becomes thermally unstable when applying certain
temperature conditions, a multiphase system containing a polymer-rich and a polymer-poor phase can
be generated. This is referred to as a thermally-induced phase separation (TIPS) process [57,58]. After
solvent removal, the polymer-rich phase will form a 3D matrix with the polymer-poor phase constituting
the pores of the matrix. The process typically consists of five different steps: (1) dissolution of the
raw polymer in an appropriate solvent, (2) phase separation and gelation, (3) solvent extraction from
the gel (polymer-rich phase), (4) freezing and (5) drying (see Figure 3) [34,59]. The porosity and fiber
size of the fabricated TE scaffolds can be tuned by controlling different process parameters including
polymer/solvent system, polymer concentration, gelation temperature and gelation duration [60,61].
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Figure 3. Illustration of thermally-induced phase separation (TIPS) production steps.
Using TIPS, 3D nanofibrous scaffolds have been first prepared from poly-l-lactic acid (PLLA) in
1999 by Ma et al. [62]. In this pioneering study, PLLA was dissolved in tetrahydrofuran (THF) and the
effect of polymer concentration and gelation temperature was studied in detail. The applied gelation
duration depended on polymer concentration and gelation te perature and as therefore varied
between 5 min and 24 h. A scan ing electron icr sc ( ) icr r f the scaffold gained in 5
w/v% polymer concentration, a gelation temperature f ◦ ration of 25 in can be
seen in Figure 4. This image clearly shows the fabricatio of a 3 -i t o ly oriented
fibrous PL A network with fiber dia et .
Results obtained by Ma et al. also revealed that such a 3D nanofibrous network was only obtained
from a 5 w/v% PLLA/THF solution at low temperatures of gelation (15 ◦C, 8 ◦C, −18 ◦C and −195 ◦C).
The fiber diameter was not strongly affected by the gelation temperature as it was found to be in the
range 160–170 nm for all gelation temperatures under study. However, the inter-fiber spacing was
observed to be more uniform at lower gelation temperatures. At a gelation temperature of −18 ◦C,
the effect of PLLA concentration (1.0 to 7.5 w/v%) was also examined in detail. It was observed that
the fiber diameter did not statistically change with polymer concentration (160–170 nm). At low
PLLA concentrations, relatively large voids were however acquired characterized by non-uniform
inter-fiber spacing, while through enhancing the PLLA concentration, the pore structure became
growingly homogenous and symmetrical, with the presence of smaller pores. Indeed, the porosity
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was found to decrease from 98.5% to 93.8% with increasing PLLA concentration. Later on, in 2004,
Yang et al. [63] reported results similar to these of Ma et al. as these authors also showed the formation
of porous nanofibrous scaffolds generated by TIPS from low concentration PLLA/THF solutions (2 to
7 w/v%). In this case, phase separation was performed at −30 ◦C for 2 h. Additionally, the authors also
observed that when the PLLA concentration was further increased to 9 w/v%, scaffolds similar to a
piece of rigid sheet without any pores were obtained. The authors also confirmed other conclusions
of Ma et al. as they also observed a stable fiber diameter and a decreasing porosity with increasing
PLLA concentration.
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Figure 4. Scanning electron microscopy (SEM) micrograph of poly-l-lactic acid (PLLA) nanofibrous
meshes prepared from a 5 w/v% PLLA/tetrahydrofuran (THF) solution at 8 ◦C—reproduced. Reproduced
with permission from [62], Copyright Wiley, 1999.
Unfortunately, making use of the system PLLA/THF, the nanofibrous scaffolds were found to
suffer from small size (<10 µm) micropores as in this case it was very hard to simultaneously fabricate
nanofibers and a macro/microporous structure. These small size micropores strongly hamper the
application of these scaffolds in TE as the scaffold pores need to be sufficiently large to allow cell
ingrowth and nutrient exchange. To cope with this issue, He et al. [64] decided to examine a novel
ternary system consisting of PLLA/dioxane/water. The authors observed that compressed and uniform
nanofibers were fabricated using a PLLA/THF system after gelation at −30 ◦C for 2 h. In this case,
micropores were clearly visible but unfortunately, their diameter was found to be below 10 µm.
In contrast, a scaffold that is characterized by random, interconnected micropores and a nanofibrous
mesh could be fabricated from a PLLA/dioxane/water (88/12 v/v) solution at a 12 ◦C gelation temperature
for 2 h. The average pore size in this case was found to be 50 µm, which is much larger than the
pore size of the scaffolds made from PLLA/THF. The micropore walls were found to be made up of
PLLA nanofibers with fiber diameters varying from 50 nm to 200 nm. It was thus concluded that a
porous scaffold with a nanofibrous structure and large pore sizes suitable for TE applications could be
obtained by phase separation of a PLLA/dioxane/water system.
Besides the mixture of dioxane/water, also the potential of N,N-dimethylformamide (DMF) as
a solvent for PLLA has been examined in TIPS experiments. Figure 5 shows SEM images of PLLA
nanostructures obtained from PLLA/DMF solutions as a function of PLLA concentration for a gelation
process of 10 min at −10 ◦C. At a low PLLA concentration of 1 w/v%, very densely packed, randomly
organized long PLLA nanofibers with an average fiber diameter of 110–180 nm were obtained. When
the PLLA concentration was increased to 3 w/v%, a PLLA fibrous mat composed of disordered
nanofibers was still obtained, however, some of the nanofibers tend to bundle together to form a
sheaf-like structure (indicated by an arrow in Figure 5B). When the concentration was further increased
to 5 and 7 w/v%, the scaffold morphology changed to highly porous microspheres with a diameter of
30–70 µm, composed of thin fluffy PLLA nanofibers (average diameter = 150 nm) [65].
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crucial role as with increasing water am unt, the nanofibrous assembly was found to disappear [66].
Very recently, highly porous nanofibrous membranes were also successfully fabricated through low
temperature-induced phase separation of a chitosan solution i a tertiary solvent mixture (acetic
acid/water/ethanol) [67]. Unlike crystalline PLLA, which can organize into nanofibrous struct res in a
gelation duration of only 10 min, the assembly of semi-crystalli e chitosan into nan fibers is a very
slow process with typical gelation duration of 8 to 10 h. In this case, the chitosan concentration was
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fixed at 2 w/v%, the optimum quenching temperature and time were found to be equal to −20 ◦C to
fabricate highly porous nanofibers with diameters of 40–60 nm [67].
TIPS can be combined with other processing techniques, such as granular leaching or solid-free
structure fabrication, to produce scaffolds with complicated porous structures and precise morphology
of the pores [68–70]. For instance, sodium chloride granules with a diameter of 200–450 µm were stirred
with a warm solution of poly(lactic-co-glycolic acid) (PLGA) in THF, after which the temperature of
the solution was decreased to a gelation temperature (−21 or −70 ◦C) which was set in advance [68].
The fabricated composite gels were subsequently extracted using cold ethanol and to filter the salt
particles and remove the remaining solvent, the obtained gels were washed with deionized water.
After freeze-drying, a nanofibrous PLGA scaffold containing macropores, left behind by the leached
salt, was obtained.
To conclude, it can be stated that TIPS is a promising technique for the development of nanofibrous
scaffolds containing precise pores, pore shapes, and pore sizes. While this method can be easily used
together with other production strategies to tune the final 3D structure, the approach also suffers
from some important drawbacks. The long fabrication time, the lack of mechanical properties and
the limited control over fiber orientation and diameter are some important issues, which should be
investigated further to obtain better control over the produced nanofibrous TE scaffolds.
2.2. Molecular Self-Assembly
Very recently, molecular self-assembly is gaining attention as a novel technique to prepare
nanofibrous TE scaffolds [71–74]. In contrast to TIPS and electrospinning, which are top-down
approaches, molecular self-assembly is a bottom-up method relying on the spontaneous arrangement
of single macromolecules (basic units) into stable nanoscale supramolecular structures [75–77].
When appropriate stimuli are present, biomolecules have an inert tendency to self-assemble into
supramolecular structures. Hydrophobic forces are the major driving forces for self-assembly and
the self-assembled structures are typically stabilized by various attractive forces, like electrostatic
interactions, hydrogen bonds, van der Waals forces [36,75,76,78]. As such, very stable molecular
assemblies can be obtained despite the fact that all involved bonds are rather weak [36,78,79].
The structure of the self-assembled materials can be typically tuned by controlling the kinetics, the
molecular chemistry and the assembly environment (for example pH, solvent, light, salt addition
and temperature) [80]. However, the main difficulty in molecular assembly is to create molecular
units that are able to trigger spontaneous arrangements into a precise structure, which mimics the
nanostructured characteristics of the ECM [60].
Among different building blocks which can self-assemble into nanofibrous scaffolds (nucleic
acids, proteins, and peptides), peptide-amphiphile (PA) blocks that integrate the activities of peptides
with surfactant properties, have drawn a lot of attraction in TE applications as a result of their design
flexibility and their ability to self-assemble in aqueous media [35,81]. The chemical design of a PA
unit is typically composed of 4 main structural characteristics, as schematically depicted in Figure 6A.
The hydrophobic tail is the first division which commonly consists of a long, saturated alkyl domain.
Right next to the tail is the second section, which is made up of a small peptide sequence triggering
hydrogen bonding by the creation of intermolecular β-sheets [82,83]. A third part is usually composed
of acidic or basic amino acids to induce charge, promote water solubility and structural alternations
(e.g., salt addition or gelation using a pH shift). The last segment, at the final point opposite the
hydrophobic tail, is present to provide a bioactive signal to the unit and may be comprised of an epitope
to engage with cell receptors, a section that immobilizes proteins or biomolecules or a pharmacological
drug [82,83].
The main function of the hydrophobic tail, a crucial element in self-assembled systems,
is strengthening the amphiphilic nature of the molecule. The amphiphilic nature of the molecule
causes the alkyl moiety to collapse hydrophobically into the core of the nanostructure. As a result, the
attached peptides are particularly placed on the surface of the nanofibers, where they can be easily
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accessed by cells, proteins or other biological targets. In aqueous solutions, the following three major
forces are controlling the self-assembly of PA units: hydrophobic collapse of the alkyl tails, hydrogen
interactions and side-chain bonding in the main peptide sections and electrostatic repulsions within
the charged amino acids [82,83]. The interplay between all these interactions determine the ultimate
architecture of the assembled PA units [78,81–83].
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In 2002, Hartgerink et al. [84] showed that the self-assembly process into nanofibers can be
influenced by tuning the hydrophobic tail. In a first step, these authors examined the influence of
the hydrophobic tail length on the self-asse bly process by varying the tail length from as long as a
22-carbon fatty acid to molecules containing no fatty acid at all. The authors observed that only the
10-, 16- and 22-carbon fatty acid were able to result in the formation of a dense network of fibers in
excess of 1 µm long possessing fiber diameter in the range 5–8 nm [84]. The authors also observed that
when the PAs with longer hydrophobic tails are oxidized, the self-assembly process into nanofibers is
suppressed due to the formation of intramolecular disulfide bonds.
Peptide epitopes are another crucial element in self-assembling PAs and are located at the end of
the molecule, opposite the hydrophobic tail. These epitopes enable the display of bioactive signals
at controllable densities on the surface of the supramolecular nanofiber. For instance, in the case
of interaction of cells with PAs, choosing epitopes that promote cell attachment is often favorable.
RGDS, a short peptide epitope that is present in most of the ECM proteins, especially in fibronectin,
is also known as a common epitope that improves initial cell attachment [82]. As a result, RGDS
has been frequently incorporated into PAs to improve the biological response of the PAs [85,86].
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Another commonly used epitope is the laminin-derived isolucinelysine-valine-alanine-valine (IKVAV),
a pentapeptide sequence crucial for neuron cell adhesion, proliferation, migration and neurite
growth [87,88]. Consequently, IKVAV has been often incorporated into PAs to improve their bioactivity
in nerve TE applications [89–91]. A transmission electron microscopy (TEM) image of nanofibers,
self-assembled from an IKVAV-terminated PA, can be found in Figure 6C showing several micrometers
long nanofibers with nearly uniform fiber diameters of 7 ± 1 nm [81].
By controlling the process parameters, it is possible to tune the structural properties of the
nanostructures obtained through PA molecular self-assembly. A widely used approach to tune the
shape of the assembled nanostructures is by making alterations to the design of the β-sheet peptide
segment. At first, it was found that modifications of this peptide part did not strongly affect the
structure of the self-assembled PAs as in all cases cylindrical nanofibers were produced [83]. On the
other hand, when sequences of alternating hydrophobic and hydrophilic amino acids were used,
specific PAs were observed to self-assemble into completely flat nanobelts possessing a monodisperse
width of 150 nm and lengths up to 0.1 mm [92]. In another study, Hung and Stupp generated bundles
of aligned PA nanofibers by self-assembling PAs within parallel channels [93]. More information on
other strategies used to tune the final morphology of PA nanostructures can be found in the review
paper written by Webber et al. [82]. Researchers have also observed that 3D hydrogel networks, which
mimic the highly hydrated nanofibrous structure of native ECM, can also be created from by the
self-assembly of 1D PA nanofibers [82,94]. An example of such an IKVAV nanofiber gel network can be
found in Figure 6C.
To be applied in the field of TE, the self-assembled supramolecular structures should have a
length scale more similar to natural tissues [94]. In an effort to obtain a higher length scale, some
hierarchical supramolecular PA assemblies have been developed [95,96]. In a recent study, Capito
and co-workers obtained a highly ordered architecture by adding drops of a negatively charged
hyaluronic acid (HA) solution into a positively charged PA solution [95]. Upon contact of the two
solutions, PA molecules promptly formed aligned bundles perpendicular to the diffusion barrier
at the liquid–liquid interconnected layer, resulting in the production of a microsac-like mesh. This
mesh could be penetrated by proteins and growth factors which in turn resulted in an excellent
viability of encapsulated stem cells up to four weeks. Furthermore, when chondrogenic media were
added, the cells even differentiated into chondrocytes. This unique microsac-like mesh could thus be
potentially used in different regenerative medicine applications such as TE scaffolds or drug delivery
vehicles. In another study, Zhang et al. [96] successfully fabricated massively aligned PA nanofiber
bundles highly resembling the strongly aligned extracelullar fibrils in the brain, spinal cord and heart
tissue. A simple heat and cool approach was used in their paper to obtain an aqueous liquid crystal
solution: in a first step, the PA solution was dehydrated using heating after which a slow cooling
process was conducted to transform the bundled fibers into a liquid crystalline solution. In the next
step, this solution was added to a calcium chloride solution resulting in the fabrication of aligned fibers
with macroscale length, which could potentially be used as artificial blood vessels.
To conclude, it can be stated that molecular self-assembly is a relatively new approach to fabricate
nanofibrous TE scaffolds. As a result, several technical hurdles still need to be addressed at this
moment before the self-assembled nanofibrous structures can be successfully applied in the field of TE.
For example, excellent control over pore size and pore structure has not yet been achieved although
these are important parameters strongly affecting cell adhesion, proliferation, and migration. Moreover,
there is no information on the degradation rate of these self-assembled nanostructures [97]. Finally,
the mechanical properties of most self-assembled scaffolds are very poor and absolutely not sufficient
to tolerate the mechanical forces coming from surrounding tissues.
2.3. Electrospinning
Electrospinning is an electrostatically driven process employed for the fabrication of inter-porous
nanofibrous meshes from a huge range of materials such as polymers [98,99], inorganics and hybrid
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(organic–inorganic) compounds [100]. This nanofiber fabrication technique has been introduced in the
1930s, however, its applications were limited to filtration until the 1990s [101]. From that moment on,
the technique also started to attract interest in other application fields due to the possible utilization of
a wide variety of starting materials. Compared to the above-mentioned techniques, electrospinning is
by far the most commonly used nanofibrous scaffold fabrication technique (see Figure 2) due to its
cost-effectiveness [102], its simplicity [40], its immense versatility [103], its readiness for industrial
scale-up and its large flexibility [104].
In the field of TE engineering, most attention has been paid to the fabrication of electrospun
polymer-based nanofibrous scaffolds and only these polymeric electrospun scaffolds will, therefore,
be described in this paper. In this case, the formation of nanofibers is based on the uniaxial stretching
of a viscoelastic liquid polymer solution (Figure 7A) or polymer melt (Figure 7B) using an electric field
to eject a thin liquid jet from a needle or small capillary tube. Using this technique, nanofibers can
be fabricated from a wide range of polymers or copolymers with diameters ranging from 3 nm up to
10 mm. Moreover, a variety of (macro) molecules can also be incorporated during the electrospinning
process to produce highly-functionalized nanofibers [101,105] again evidencing the high flexibility of
the electrospinning process.
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constructed from electric conductors to neutralize the charge carried by the nanofibers [37,101,109,110].
As most attention in the field of TE has been paid to solution electrospinning, only this technique
will be further elaborated in this review paper. More information on melt electrospinning and its
application in TE can be found in an interesting review written by Muerza-Cascante et al. [111].
The physical properties of polymeric nanofibers fabricated by solution electrospinning can be
controlled by a multitude of electrospinning parameters: (1) solution properties such as type of polymer,
polymer concentration, polymer molecular weight, which in turn determine the solution viscosity,
solution conductivity, and solution surface tension; (2) electrospinning process variables such as applied
voltage, collector composition and geometry, capillary-to-collector distance, polymer solution feed rate
and orifice size and (3) ambient parameters such as relative humidity, temperature and surrounded
air velocity in the chamber [112]. As multiple review papers [37,113,114] have already described the
effect of each of the mentioned parameters on the final physical characteristics of polymeric nanofibers,
the reader is referred to these excellent papers to gather more information on this topic. Each of the
above-mentioned parameters needs to be carefully controlled for each polymer/solvent combination to
obtain nicely elongated, bead-free polymeric nanofibers.
In a classical electrospinning set-up using a flat collector or a low-speed rotating cylindrical
collector, the electrospun nanofibers are randomly arranged with interconnecting pores, as depicted in
Figure 8A, which shows a PCL nanofibrous mat obtained from a 14% w/v PCL solution in a ratio of 9:1
formic acid/acetic acid mixture using a slowly rotating cylindrical collector. For some TE applications
like nerve or tendon regeneration, it is however required to construct electrospun nanofibrous scaffolds
consisting of aligned nanofibers, as the orientation of the nanofibers can have a positive influence
on the mechanical properties of the scaffold and can aid to guide the orientation of cells seeded on
these scaffolds [37]. For example, Chew et al. [115] and Wang et al. [116] reported the influence of
aligned electrospun nanofibrous mats on the guidance of cultured cells and observed that nanofiber
alignment can facilitate the elongation and orientation of cells along the alignment axis. Currently,
a number of alternative electrospinning collectors have been developed to obtain aligned electrospun
nanofibers [117,118], which can be categorized into 3 groups according to the type of forces used for
fiber alignment: (1) a disc or mandrel with high-speed rotation (mechanical forces) [119]; (2) parallel
electrodes (electrostatic forces) and (3) parallel permanent magnets (magnetic forces) [120]. More
information regarding these special collectors can be found in the review paper of Toe et al. [117].
An example of aligned electrospun PCL nanofibers obtained from a 14% w/v PCL solution in a ratio of 9:1
formic acid/acetic acid mixture using a fast rotating disc (3000 rpm) can be observed in Figure 8B [119].
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channels, as schematically depicted in Figure 9. The polymer solution constituting the outer layer
of the nanofibers (the so-called sheath polymer solution) typically carries the charge and its conical
shape at the tip of the needle/capillary causes the core layer formed by the so-called core polymer
solution to deform. As a consequence, using this technique, some difficult–to–spin polymers can also
be electrospun as they can form an ultrafine core inside the shell of an easily spinnable polymer. In a
later stage, the polymer shell can be dissolved/removed, thereby revealing the spin-target polymer
nanofiber. A similar concept can also be used to remove the core of the resultant nanofibers to fabricate
hollow nanofibers by choosing a core polymer solution which can be post-spinning dissolved in a
particular solvent and by selecting a sheath layer which is insoluble in the same solvent. Currently,
there are different studies available focusing on the fabrication of core-sheath and hollow polymeric
nanofibers [125–127]. Inside hollow polymeric nanofibers, biologically active agents (for example,
drugs) can be encapsulated to form a drug delivery device [121]. Core–sheath nanofibers are also very
interesting for TE applications as they can facilitate tissue regeneration processes by the incorporation
of biomolecules (for example peptide or growth factors) into the core of core-shell nanofibers [128,129].
Additionally, by adding different components to the core and shell of core-shell nanofibers, the
simultaneous release of these components during the tissue regeneration process can be achieved [130].
Compared to single component nanofibers, these hollow and coaxial nanofibers can have several
benefits in biomedical applications: (1) bioactive agents present in the core are not exposed to a harsh
chemical environment as they are shielded by the surrounding shell part; (2) by carefully controlling
the thickness of the core and shell layer, a well-controlled release of a drug can be obtained; (3) by
selecting two suitable compounds, the coaxial nanofibers can have excellent mechanical properties and
(4) a polymer with a higher biocompatibility can be chosen as sheath material while a polymer with
lower biocompatibility can be used as a core [120].
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From the above, it can be cl e t l t i fi eshes with
interco nected pores can be produced, w ich are strongly resembling the natural ECM. As such,
these electrospun meshes can potentially be used as scaffolds in the field of TE. the
nanofibrous meshes fabricated through conventional electrospinning are rather
than 3D, thereby preventing the required ce l diff sion f r . t i iss ,
several a proaches to form 3D l ctr s ff lre been developed. co only
Nanomaterials 2020, 10, 119 13 of 63
applied technique is using a liquid reservoir as a collector during the electrospinning process: when
low surface tension liquids such as methanol, ethanol, and water are used, the electrospun nanofibers
sink during electrospinning process minimizing fiber bonding [132]. This results in the fabrication of a
fluffy layer of nanofibrous meshes with higher internal porosity [133]. Tubular electrospun nanofibrous
conduits can also be produced by depositing fibers on a small diameter cylindrical collector [134].
These tubular conduits are commonly used in nerve or vascular TE as they are able to resemble the
structure of these tissues [135–137]. For example, electrospun nanofiber conduits have been fabricated
with a length of 10 mm and a total wall thickness of 155 µm by electrospinning a mixture of PCL and
PLGA on a rotating rod possessing a diameter of 1.29 mm [138]. In a first step, pure PCL nanofibers
were electrospun with an average diameter of 7.5 ± 2.0 µm, followed by the electrospinning of a mixture
of PCL and PLGA resulting in the deposition of PCL/PLGA nanofibers with an average fiber diameter
of 279 ± 87 nm. An SEM image of the obtained electrospun conduit can be seen in Figure 10A, while
an SEM image of the conduit wall can be observed in Figure 10B. Additional information regarding the
formation of 3D electrospun scaffolds can be found in a recent review paper written by Jun et al. [132].Nano aterials 2020, 10, x FOR PEER REVIEW 13 of 61 
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Currently, significant attention is being paid to the up-scaling of the electrospinning process to
enable mass production of electrospun nanofibrous mats. In a laboratory setting, researchers are mostly
using polymer volumes in the range of milliliters although it is possible to electrospin several liters of
a polymer solution in a continuous run using a lab-scaled electrospinning process. The most important
limitations to up-scale the electrospinning process are mentioned hereafter: (1) for most materials, the
maximal attainable length range of electrospun nanofibers is ranging from hundreds of micrometers to
millimeters. As such, electrospinning presents poor reproducibility when applying it on a commercial
scale. (2) Optimization of the electrospinning process is not easy due to the weak viscoelastic character
of most polymer solutions, the poor solubility of polymers into different solvents, the lack of adequate
molecular entanglements, and, more generally, because only some of the electrospinning processing
parameters can be easily varied. Up to now, several researchers are however trying to increase the
productivity of the electrospinning process as comprehensively discussed in the review paper of
Persano et al. [104]. The most relevant technological improvements that have, to date, been investigated
to promote the mass production of electrospun mats are mainly based on the modification on modifying
the system of polymer injection and consist of: (1) the use of multi-spinnerets that allow parallel
multi-processing [139] and (2) the introduction of free surface or so-called needleless electrospinning
methods [140], such as for example bubble electrospinning [141] and roller electrospinning [142]. More
Nanomaterials 2020, 10, 119 14 of 63
in-depth knowledge of multi-needle and needleless electrospinning can be found in the review papers
written by Yu et al. [143] and Persano et al. [104].
2.4. Comparison of Different Nanofibrous Scaffold Fabrication Techniques
To conclude the part on the fabrication of nanofibrous TE scaffolds, it can be stated that selecting the
most suited method for nanofiber fabrication highly depends on two main factors: (1) the envisioned
starting materials as the used technique should not damage or denature these materials during the
nanofiber fabrication process when using solvents, high voltage, heating, etc., and (2) the foreseen
application which typically specifies the required nanofiber morphology like fiber diameter, porosity,
fiber direction, required fiber alignment and fiber length. A general overview of the advantages and
disadvantages of each described nanofiber fabrication technique can be found in Table 1, helping the
reader to obtain a general overview of the pros and cons of each method. In the next section, the
most widely applied synthetic polymers used to generate electrospun nanofibrous scaffolds will be
briefly discussed to help researchers choosing the most appropriate synthetic polymer for a practical
envisioned TE application.
Table 1. Advantages and disadvantages of different techniques for polymer nanofibrous
scaffold fabrication.
Technique Ease of Processing Advantages Disadvantages
Phase separation Easy
• 3D pore arrangement









• Limited range of
polymers can be used
Self-assembly Difficult
• Easy incorporation of
cells during
fiber formation
• 3D pore arrangement
• Injectable in vivo
• Great control of 3D shape
• Easy to fabricate
nanofibers on a low scale
• Very complex procedure
• Limited fiber diameter
and short fibers




• Limited range of




• Long continuous fibers










• Poor cell infiltration into
the scaffolds’ core
• Mostly 2D scaffolds
• Usage of toxic solvents
• Difficult to control pore
size and shape
3. Synthetic Biodegradable Polyesters Used to Fabricate Electrospun TE Scaffolds
As mentioned in the previous section, of all the current strategies available for synthesizing
polymeric nanofibers, electrospinning is considered the most straightforward and cost-effective
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technique. Although a large variety of natural and synthetic polymers has already been successfully
electrospun into TE scaffolds, this section will only focus on biodegradable aliphatic polyesters as
these polymeric materials are the most commonly used for the fabrication of nanofibrous TE scaffolds
using solvent electrospinning [144]. Their success in the biomedical field is based on their excellent
mechanical properties, their high biocompatibility and their intrinsic biodegradable properties [145].
Indeed, when incubated in aqueous solutions, aliphatic polyesters undergo hydrolytic degradation
of the present ester linkages. This degradation process strongly depends on the length of the alkane
backbone and complete degradation of aliphatic polyesters typically occurs in a timeframe of a few
months up to several years, depending on their chemical structure [146–148]. Due to their relatively
slow degradation process, aliphatic polyesters are mainly investigated as a material for long-term TE
applications [147,148]. In the following, the most important aliphatic polyesters (chemical structures
shown in Figure 11) will be shortly described. Additionally, the fabrication of electrospun nanofibrous
scaffolds from these polyesters will also be reviewed.Nanomaterials 2020, 10, x FOR PEER REVIEW 15 of 61 
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3.1. Polyglycolic Acid
Polyglycolic acid (PGA) or polyglycolide is the simplest linear aliphatic polyester and is a rigid
thermoplastic polymer. PGA is a crystalline polymer with a high degree of crystallinity (44–55%) and
consequently shows great mechanical properties. At the same time, it also shows low solubility in most
organic solvents, making it difficult to use PGA for solvent electrospinning [149–152]. PGA is however
soluble in highly-fluorinated solvents, such as for example hexafluoroisopropanol (HFIP). The PGA
degradation procedure commonly takes place in two steps: firstly, hydrolytic chain scission of the
ester group occurs as a result of water diffusion into the amorphous regions of the polymer. Secondly,
after erosion of the amorphous parts, the hydrolytic attack of the crystalline parts of the polymer
starts to occur. PGA loses its strength within 1–2 months after initiation of the hydrolysis process and
loses its mass over 6 to 12 months. In vivo, glycolic acid is produced as a result of PGA degradation.
This degradation product is non-toxic and can be either removed from the body through the urine or
converted into CO2 and water which can be excreted via the respiratory system [150,151,153].
PGA has already been successfully electrospun starting from a PGA solution in HFIP with
PGA concentration varying between 5 and 14 w/v%. Over the examined PGA concentration range,
electrospun PGA nanofibers were generated with average fiber diameters ranging from 110 nm
to 1.19 µm with higher fiber diameters obtained at higher PGA concentrations. Using these PGA
solutions, nicely elongated electrospun PGA nanofibers were only obtained at PGA concentrations
above 10 w/v%, while at lower PGA concentrations, beads were found to be present in the PGA
electrospun scaffolds [154,155], as shown in Figure 12. The high degradation rate, as well as the limited
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solubility of PGA, do limit the applicability of PGA nanofibrous TE scaffolds. Therefore, several
co-polymers of PGA have been introduced to prevail the inherent shortcomings of PGA, of which Poly
(PLGA) is the by far the most applied co-polymer, as will be discussed later on.Nanomaterials 2020, 10, x FOR PEER REVIEW 16 of 61 
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3.2 Polylactic Acid
A second, very important biodegradable linear aliphatic polyester is polylactic acid (PLA), which is
known as one of the most promising biop lymers for TE applications [156]. Due to the chiral structure of
lactic acid, there are different types of PLA. The most commonly used ones are PLLA poly (l-lactic acid)
and poly (dl-lactic acid) (PDLA). Similar to PGA, PLLA is a crystalline polymer possessing roughly 37%
of crystallinity depending on molecular weight and the conditions of polymer processing. Compared
to PGA, PLLA is also a more slowly-degrading polymer: when being hydrolyzed, the polymer loses its
strength in almost 6 months. However, no remarkable alternation in mass occurs for a long term and
complete resorption of high molecular weight PLLA can occur only after several years. In addition
to the low degradation rate, PLLA also has excellent tensile strength, a high tensile modulus, and a
low elongation at break. In contrast, PDLA is an amorphous polymer which consequently shows a
smaller strength value than PLLA. Additionally, PDLA also degrades faster than PLLA: it loses its
strength in 1 to 2 months as a result of hydrolysis and loses mass within 12 to 16 months. In vivo, PLA
is hydrolyzed into its repeating unit, lactic acid. This chemical compound is a normal human metabolic
by-product and is in vivo degraded to water and CO2, which can be subsequently removed by the
human respiratory system. Due to their excellent solubility in different solvents, PLLA and PDLA
have been successf lly electrospu starting from different polymer/solvent systems, although mostly
chlorinated and fluorinated solvents have been used. An overvi w of some exampl s of the fabrication
of electrospun PLLA a d PDLA scaffolds can be fou d i Tables 2 and 3 respectively combined with
the applied electrospinning parameters and the obtained nanofiber characteristics.
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3.3. Poly-ε-Caprolactone
One of the most widely applied aliphatic polyesters to fabricate electrospun TE scaffolds is PCL.
PCL is a semi-crystalline synthetic polymer in which has a very low glass-transition temperature
(approximately −62 ◦C), making it highly elastic at room temperature. PCL also has a low melting point
of 55–60 ◦C, depending on the degree of crystallinity, which is in turn dictated by the molecular weight
and the scaffold fabrication process. Additionally, PCL is readily soluble in a wide range of organic
solvents, making it an easy-to-electrospin polymer. Due to its semi-crystalline and hydrophobic nature,
PCL exhibits a very slow degradation rate (2–4 years depending on the starting molecular weight)
and has mechanical properties suitable for TE applications [166]. Like the earlier discussed aliphatic
polyesters, PCL also hydrolytically degrades owing to the presence of ester linkages. Some examples of
the successful fabrication of electrospun PCL nanofibrous scaffolds for TE applications can be found in
Table 4. This table clearly reveals that the use of chlorinated solvents results in the fabrication of rather
thick PCL nanofibers (fiber diameter >400 nm), while the use of the solvent mixture formic acid/acetic
acid results in very thin PCL nanofibers possessing an average fiber diameter close to 100 nm.
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3.4. Poly (Lactic-Co-Glycolic acid)
In an effort to tune the mechanical properties and the degradation kinetics of aliphatic
biodegradable polyesters, different co-polyesters have also been developed, of which the amorphous
PLGA is by far the most widely applied as starting material for TE scaffolds. In contrary to the
homo-polymers of lactic acid and glycolic acid which show a rather poor solubility, PLGA is easily
soluble in a wide variety of solvents. PLGA also degrades through ester bond hydrolysis and the
degradation rate of PLGA can be carefully controlled by changing the lactic acid/glycolic acid ratio.
For example, PLGA with a PLA: PGA ratio of 85:15 degrades in 5–6 months, while PLGA with a PLA:
PGA ratio of 50:50 degrades in 1 to 2 months. In fact, increasing the percentage of glycolic acid with
respect to lactic acid in the copolymer generally increases the rate of degradation both in vitro and
in vivo [173]. PLGA nanofibers with varying lactic acid/glycolic acid ratios have been successfully
fabricated making use of solvent electrospinning. Some selected examples of PLGA electrospinning
are presented in Table 5 in combination with the used electrospinning parameters and the obtained
PLGA nanofiber morphology.
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3.5. Other Co-Polyesters
Besides PLGA, also other co-polyesters such as PCL/PLA and PCL/PGA have been investigated
as possible TE scaffolds in an effort to further tune the bulk properties of TE scaffolds. In a recent
publication, Yao et al. [176] have compared the performance of 3D electrospun PCL and PCL/PLA
(mass ratio: 4/1) blend nanofibrous scaffolds in bone TE applications. The observed that compared
to the pure PCL scaffolds, PCL/PLA blend scaffolds had better mechanical properties and in vitro
bioactivity. Consequently, the blended scaffolds not only enhanced the cell viability of human
mesenchymal stem cells (hMSCs), but also promoted the osteogenic differentiation. Furthermore,
in vivo studies also revealed that the PCL/PLA scaffolds considerably facilitated new bone formation
in a critical-sized cranial bone defect mouse model. Blended PCL/PLA nanofibrous scaffolds can
thus have very important applications in bone TE. In another paper authored by Aghdami et
al. [177], randomly oriented nanofibrous meshes made of both PCL and PGA with various PCL/PGA
compositions (100/0, 80/20, 65/35, 50/50, and 0/100) were produced using solvent electrospinning.
Morphological characterization of the obtained nanofibers revealed that the nanofibers’ average
diameters increased when increasing amounts of PGA were added to PCL. Additionally, the wettability
of the nanofibrous meshes also increased when the PGA amount in the solution mixture was increased.
Finally, the mechanical characterization of the nanofibrous meshes also revealed that enhancing the
amount of PGA resulted in a tremendous increase in the mechanical properties. By changing the
PCL/PGA ratio, the morphological, chemical and mechanical properties of the TE scaffold can thus be
fine-tuned to meet the requirements for a particular TE application. Besides the blending of different
biodegradable polyesters, these polyesters can also be mixed with natural polymers for TE applications
to improve specific nanofiber characteristics such as mechanical strength, elasticity, wettability and/or
electrospinnability [173]. These blends will however not be described in this particular review paper as
numerous information regarding this topic can already be found in the very interesting review paper
of Sell et al. [178].
Although a wide range of synthetic biodegradable polyesters are utilized as electrospun TE
scaffolds, a major disadvantage of this class of materials is a lack of biological recognition on their
surface as a result of their inherent biological inert properties [179]. Indeed, surface biochemical cues
can significantly affect cell-surface behavior as they are initiator/elicitor for most of the biological
responses [180]. As such, the scaffold surface often needs to be modified to obtain more desirable
characteristics to promote cell-scaffold interactions. Despite different surface modification techniques
are available for this purpose as thoroughly reviewed in [80], this paper will particularly focus on
non-thermal plasma (NTP) surface modification, which has proven to be a very promising technique
for scaffold surface modification.
4. Plasma-Assisted Surface Modification of TE Scaffolds
As already mentioned, biodegradable aliphatic polyesters have been comprehensively investigated
as electrospun TE scaffolds as they show low immunogenicity, excellent mechanical properties, non-toxic
behavior, and controllable degradation rates. However, the hydrophobic nature and low surface energy
of these polymers often result in poor cell attachment. Consequently, modification of the surface of TE
scaffolds fabricated from synthetic polyesters is commonly required and various strategies have already
been developed to tackle this major drawback [144,181–183]. A commonly used means of surface
functionalization is through wet chemistry, which relies on the immersion of the nanofibrous scaffolds
into harsh chemicals, such as strong acids or alkalis (for example H2SO4 or NaOH) [184,185]. This
strategy enables the grafting of hydroxyl or carboxylic groups by hydrolysis through nucleophilic acyl
substitution [186]. The grafting of these oxygen-rich groups was found to improve the hydrophilicity
and initial cell attachment [185,187]. Alternatively, amino groups can also be grafted onto the surface
of TE scaffolds via aminolysis, a process in which the nanofibers are immersed in, for example,
1,6-hexanediamine [188]. Unfortunately, due to the harsh processing conditions, the bulk physical
properties easily deteriorate due to the scission of the polymer backbone [184,189]. Additionally, these
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chemical processes are usually time-consuming and generate lots of liquid waste which should be
disposed of carefully. Moreover, there is the risk of inadequate washing, which could result in the
presence of residual chemicals within the nanofibrous matrix, thereby severely compromising the
biocompatibility of the TE scaffold.
Compared to the wet chemical route, NTP-assisted surface modification of TE scaffolds is
considered to be a much more suitable technique to improve cellular interactions on TE scaffolds.
This is attributed to their numerous advantages, of which a few will be mentioned hereafter. Plasma
treatments are performed in the gaseous phase and do not use any harsh chemical, making them a
greener alternative. In addition, plasma effects are usually limited to the first few subsurface layers, not
influencing the bulk properties of TE scaffolds. On top of that, as no solvents are used, there is a minimal
risk of chemical contamination afterwards. Moreover, under the right plasma conditions, scaffolds
will only experience minimum heating, thus avoiding thermal damage to the delicate nanofibrous
structures [190]. Due to the mentioned benefits, plasma surface treatments of TE scaffolds show high
potential to enhance cell-scaffold interactions and will, therefore, be the main subject of the following
sections. First, a general introduction to plasma and different plasma set-ups will be given, followed
by a comprehensive overview of recent findings on plasma treatments of nanofibrous TE scaffolds.
4.1. Plasma Set-Ups Used for the Treatment of Nanofibrous TE Scaffolds
In physics, plasma is defined as an ionized gas consisting of positive and negative charges in
equal density and is also known as the fourth state of matter. Plasma can be categorized into 2 different
categories (thermal and non-thermal plasma), depending on its thermal equilibrium state. In the case
of a thermal plasma, also known as a hot or equilibrium plasma, the electron and ion temperature are
in equilibrium. Due to the high ion temperature, the overall gas temperature is typically several 1000 K
and this plasma type is therefore not considered suitable for the treatment of heat-sensitive materials
such as TE scaffolds. Equilibrium plasmas are mainly applied for the surface modification of metallic
and silicon-wafer surfaces which can withstand the high operating gas temperatures to deposit a thin
diamond-like coating, zinc oxide coatings and silicone films [191–194]. Other application fields can be
found in the field of nanoparticle production and the destruction of hazardous waste [195].
However, in an NTP, also known as a non-equilibrium or cold plasma, the temperatures of
electrons and ions/heavy particles are not in equilibrium. This stems from the methodology in which
the plasma is generated: by using a strong electric or magnetic field, the free electrons are accelerated,
resulting in ionization. Consequently, the relative velocity of the ions is much lower than the velocity
of the electrons. This results in the formation of a plasma state at significantly lower gas temperatures,
making these plasmas ideal for the modification of thermosensitive materials such as polymeric
nanofibrous TE scaffolds [196]. A wide range of methods is currently available to generate NTPs,
both at vacuum as well as atmospheric pressure. In this work, however, we will limit ourselves to
the 2 plasma types which are mostly used for the treatment of nanofibrous TE scaffolds: (1) dielectric
barrier discharges (DBDs) [197–200] and (2) radiofrequency (RF) discharges [201–211]. For more
information on other available NTP set-ups, the reader is referred to extended review papers, focusing
on the generation of NTPs [212–215].
One of the most popular NTP sources used for polymer surface treatment is the DBD. A DBD
set-up applied for surface treatment typically consists of two parallel electrodes separated by a small
gas gap of a few millimeters up to a few centimeters. Characteristics of a DBD are that at least one
electrode is covered with a dielectric layer such as glass, quartz or alumina (see Figure 13A). When
an AC high voltage with a frequency (typically in the range of kHz) is applied, the high intensity of
the electrical field is created between the electrodes [190]. However, also other driving modes can be
used with this plasma reactor type generating plasma discharges with characteristics different from
DBDs [216]. Due to the presence of the dielectric layer(s), the charge is homogeneously distributed
across the electrodes, encouraging the formation of micro-discharges rather than a single arc discharge.
The ionization of the gas occurs near these micro-discharges due to the acceleration of the electrons
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from the cathode to the anode by the generation of a strong electric field [217]. Collisions between
the accelerating electrons and the supplied gas cause the gas to be ionized, thereby generating and
sustaining the plasma [190,218,219]. DBDs can be easily generated at atmospheric pressure [220–226],
but also DBDs operating at medium pressure (1–10 kPa) are commonly applied for polymer surface
modification [223–225].
Besides DBDs, also RF discharges are widely applied for plasma-assisted surface modification.
RF discharges can be divided into two categories, capacitively coupled plasma (CCP) and inductively
coupled plasma (ICP), depending on the method of RF power coupling [226]. A CCP, which is mainly
generated at low pressure (10−3–1000 Pa), consists of the same electrode configuration as the one
employed for DBD reactors (2 horizontal or vertical parallel plate electrodes), but without the presence
of a dielectric [212,227]. This plasma type is mostly generated under vacuum conditions to maintain a
stable glow discharge, as higher pressures would lead to instabilities that could transition the plasma
from a (pseudo)glow mode to an arc discharge. Although CCPs can be driven by RF high voltage
sources operating between 1 and 100 MHz, a high voltage power source operating at 13.56 MHz is by far
the most used. The mechanism of ionization to generate a CCP is similar to the case of a DBD [228,229],
however, micro-discharges are not generated because the electrons and ions in the plasma do not reach
the electrodes due to the high operating frequency [212,227]. In the case of an ICP, the plasma is not
generated by oscillating electrical fields, but by oscillating magnetic fields. These, in turn, induce a
strong RF electric field in the plasma region, thereby accelerating the free electrons. Consequently,
this causes the gas to be ionized, thereby generating and sustaining the plasma phase [212]. These
discharges can be sustained without the need for the electrodes to be in contact with the plasma,
which can be a huge benefit for different applications as in this way impurities originating from the
electrodes can be prevented [230]. Although the discharges can be applied at high pressure and even at
atmospheric pressure, in most instances the discharges are operated under vacuum. Inductive coupling
is typically realized by wrapping an induction coil around a dielectric plasma chamber (helical coil
configuration), which is in turn powered by an RF power source operating at 13.56 MHz. (Figure 13C).
More recent designs employ a planar coil configuration, which consists of a flat spiral coil buffered by
a dielectric plate, which is mounted onto a metal plasma chamber at vacuum pressure containing a
substrate holder (see Figure 13D). In the latter case, the ICP is generated close to the plate and across
the coil radius through a circular magnetic field. The advantage of the planar coil configuration is
a more uniform density distribution of the ICP created across the coil dimensions, providing better
procedure controllability and reproducibility of plasma surface treatments (see Table 6) [226,231].
Table 6. Comparison of various plasma set-ups.
Plasma Set-Up Operating Frequency Properties
DBD Hz-kHz
• Insulation needed for the electrode
• Electron avalanche
• Streamer formation
• Two plasma modes (glow
and filamentary)
CCP MHz
• No insulation required for
the electrode
• Electron avalanche
• Electrons are trapped between
the electrode
• Ions are accelerated towards
self-bias electrode
ICP MHz
• Electrode is isolated from the plasma
• Plasma is generated via a rapidly
changing magnetic field
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When a material is exposed to one of the abovementioned plasma discharges, various
plasma-surface interactions are possible. Three major types of plasma reactions can be recognized based
on the outcome of the interaction: (1) plasma activation, (2) plasma polymerization and (3) plasma
etching. As the third interaction as such is not employed on nanofibrous TE scaffolds, only the first two
categories will be described in detail in this review paper. After a brief introduction of each technique,
specific examples on nanofibrous TE scaffolds will be presented.Nanomaterials 2020, 10, x FOR PEER REVIEW 25 of 61 
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4.2. Plasma Activation
When the surface of a nanofibrous TE scaffold is exposed to a plasma generated in an inert
atmosphere (such as helium (He) or argon (Ar)), active plasma speci s such as ions, electrons, and
free radicals present within the plasma will bombard the scaffold surface. This process, also known
as plasma activation, causes bond cleavage of he polymeric chains, thereby creating a surface rich
in highly reactive free radicals. After removing the sample from the plasma reactor and exposing
it to ambient air, these free surface radicals will be r pidly enched by oxygen to form different
oxygen-rich surface functional groups such as for examp e peroxides and hydroperoxides [232,233].
Oxygen or nitrogen functionalities can also be directly g afted on a surface using eactive instead of
inert discharge gasses such as for example CO2, O2, ir, N2 or NH3 [205,207,234,235]. In this case,
the plasma also leads to the creation of surface radicals. H w ver, thes radic ls rapidly react with
readily available active plasma species resulting in the direct grafting of oxygen and/or nitrogen surface
functional groups. As these incorporated functional groups are polar in nature, plasma activation is
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often applied to significantly increase the hydrophilicity of a surface, a process which is known to
strongly improve the biocompatibility of otherwise inert materials [205,236–238].
Besides envisioning an increase in surface hydrophilicity, NTPs can also be employed to make
surfaces more hydrophobic. This effect can be obtained when using fluorine-containing discharge gases
such as for example CF4 or SF6 [239–241]. In this case, non-polar fluorine-containing surface functional
groups are directly grafted on a surface, thereby significantly increasing the surface hydrophobicity.
Although plasma activation processes are considered to be non-invasive, the higher-energy particles
may lead to minor etching of nanofibrous TE scaffolds, thereby degrading their mechanical properties.
As such, considerable attention needs to be given to the use of appropriate discharge powers and/or
plasma exposure times [242,243].
In 2009, Martins et al. exposed electrospun PCL scaffolds to an RF discharge (type CCP) sustained
in O2 and Ar using two different discharge powers (20 and 30 W) and varying plasma treatment times (5
and 10 min) [243]. A strong increase in surface hydrophilicity was observed for the O2 plasma-treated
PCL scaffolds as the water contact angle (WCA) values were found to decrease from 130◦ to values
below 20◦. Considering the WCA values of Ar plasma-treated PCL scaffolds, only a decrease of 20◦ in
WCA value was observed, which means that the surface only became slightly less hydrophobic using
this discharge gas. The elemental composition of the surface of the plasma-treated biomaterials was
also characterized using X-ray photoelectron spectroscopy (XPS). The surface oxygen content on the O2
plasma-treated samples was found to increase with plasma exposure time and with applied discharge
power, however, the combination of the highest discharge power (30 W) with the highest plasma
treatment time (10 min) resulted in a decrease in surface oxygen content, most likely due to melting of
the nanofibers initiated by these very harsh plasma conditions. In case of Ar plasma treatment, an
increase in oxygen content was also observed with increasing plasma treatment time using a discharge
power of 20 W. In contrast, a discharge power of 30 W resulted in a decrease in oxygen content
compared to the untreated PCL sample, which was again caused by fiber damaging. These results thus
clearly show that plasma operating parameters need to be carefully controlled to avoid damaging of
fragile nanofibers. In a next step, Martins et al. examined the cellular interactions on all plasma-treated
PCL scaffolds under study and observed that it was possible to define plasma treatment conditions
leading to enhanced adhesion and proliferation of fibroblasts, chondrocytes and osteoblasts compared
to the untreated electrospun PCL scaffold (O2 at 30 W for 5 min and Ar at 20 W for 5 min) [243]. O2 and
Ar plasma treatments have also been conducted by Ivanova et al. [244] on electrospun PCL scaffolds
using a low-pressure RF discharge at 30 W for 2 min. These authors also observed a strong decrease
in WCA values, although some changes compared to the work of Martins et al. could be noticed. In
the work of Ivanova et al. [244], the Ar plasma treatment was found to decrease the WCA by over
50◦, while in the case of O2 plasma treatments, the WCA value was observed to decrease with more
than 90◦. The authors also observed a strong scaffold surface oxidation resulting from both Ar as well
as O2 plasma treatments and suggested that in case of Ar plasma this oxidation may be originating
from the presence of residual air in the plasma chamber or from the interaction of scaffold surface
radicals with ambient air. Very recently, Asadian et al. used a medium pressure DBD sustained in Ar
to modify the surface properties of electrospun PCL nanofibrous meshes [180]. A low discharge power
of 1.8 W was used with treatment times up to 70 s. Similar observations as previously mentioned
were done: Ar plasma treatment resulted in a strongly increased surface hydrophilicity due to the
incorporation of oxygen-containing functional groups. SEM images also revealed that the morphology
and the surface roughness of the PCL nanofibers remained unaffected by the conducted Ar plasma
treatment, resulting from the mild plasma conditions. Additionally, the Ar plasma treatment was
found to strongly enhance the adhesion and proliferation of human foreskin fibroblasts (HFFs), as
evidenced by the fluorescent images taken one day and seven days post-seeding shown in Figure 14.
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impact of the performed plasma treatment on initial cell adhesion using porcine mesenchymal stem 
cells (pMSCs) and observed significantly enhanced cell adhesion on the plasma-modified PLLA 
sample. Moreover, results also revealed that plasma modification significantly affected the morphology 
of pMSCs, as schematically shown in Figure 15: in the case of pristine PLLA samples, pMSCs showed 
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PLLA, it is hard for integrin receptors to find required binding sites to adhere to during the initial 
attachment procedure. Consequently, a ball-shaped cell morphology is observed at early time intervals 
(Figure 15A). After 20 min of culturing, focal adhesion occurred resulting only in very slight stretching 
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which in turn improved the wettability of the PLLA nanofibers and supplied sufficient specific binding 
groups for integrin receptors to adhere to (Figure 15C). According to the authors, this could be a 
Figure 14. Fluorescent images one day (top) and seven days (bottom) post-seeding of human
foreskin fibroblasts (HFF) cells after culturing on untreated and Ar plasma-modified PCL nanofibrous
meshes—reproduced with permission from [106]. Copyright American Chemical Society, 2018.
Next to PCL, also nanofibrous PLLA scaffolds have been functionalized using an O2 plasma. In 2014,
Liu et al. used a low-pressure RF discharge to treat PLLA scaffolds, unfortunately, the used discharge
power, as well as the applied plasma exposure time, were not mentioned in their publication [245].
It was found that the hydrophilicity of the PLLA nanofibers was strongly improved as the WCA value
decreased from approximately 128◦ to 48◦. Again, this enhanced wettability was attributed to the
incorporation of oxygen-containing groups on the PLLA surfaces. The authors also investigated the
impact of the performed plasma treatment on initial cell adhesion using porcine mesenchymal stem
cells (pMSCs) and observed significantly enhanced cell adhesion on the plasma-modified PLLA sample.
Moreover, results also revealed that plasma modification significantly affected the morphology of
pMSCs, as schematically shown in Figure 15: in the case of pristine PLLA samples, pMSCs showed a
round-shaped morphology 10 and 20 min post-seeding, while 30 to 60 min after seeding, the pMSCs
started to slightly stretch. In contrast, on the plasma-treated PLLA scaffolds, a 2D planar morphology of
the pMSCs was observed 10 and 20 min post-seeding. In addition, 30 to 60 min after seeding, the pMSCs
were found to exhibit a 3D stretched morphology. These observations can be explained as follows: due
to the high hydrophobic nature and lack of bioactive groups on the surface of pristine PLLA, it is hard
for integrin receptors to find required binding sites to adhere to during the initial attachment procedure.
Consequently, a ball-shaped cell morphology is observed at early time intervals (Figure 15A). After
20 min of culturing, focal adhesion occurred resulting only in very slight stretching of the cells on the
nanofibrous PLLA surface (Figure 15B). As previously mentioned, O2 plasma modification resulted in
the incorporation of oxygen-containing polar groups at the PLLA surface, which in turn improved
the wettability of the PLLA nanofibers and supplied sufficient specific binding groups for integrin
receptors to adhere to (Figure 15C). According to the authors, this could be a possible reason for the
observed 2D flat morphology of pMSCs in the culture interval 10–20 min. At longer culture times,
reassembly of cytoskeletal filaments caused a change of 2D to 3D cell morphology. However, due to the
promoted hydrophilicity and enhanced number of oxygen-containing groups on the plasma-treated
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scaffolds, the cells still stretched considerably on the nanofibrous surface in comparison to the pristine
sample (Figure 15D).
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PLLA nanofibrous scaffolds (PLLA NFS) and O2 plasma-treated PLLA nanofibrous scaffolds (P-PLLA
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Similar to PCL, also the i t l t t ent has b en investigated on P LA [247].
Surface treatment of PLLA microfi r s es es as erf r ed using a vacuum RF plasma reactor
(type CCP). r plas a modification was conducted for 2 min under conditions of 30 W power.
In this case, the WCA value was found to decrease from 116◦ to 85◦ upon plasma treatment without
physically changing the PLLA fiber morphology. In this particular paper, however, no enhancement
in surface oxygen content was detected on the plasma-treated PLLA scaffold, which is in contrast to
what is typically described in the literature. Cell studies revealed that both bovine aorta endothelial
cells (BAECs) and bovine smooth muscle cells (BSMCs) adhered more and spread better on the
plasma-treated scaffold compared to the untreated sample. Additionally, the applied Ar plasma
treatment also strongly increased the proliferation rate of both cell types compared to the control
scaffold. The authors have also conducted in vitro and in vivo studies to investigate the impact of
the Ar plasma modification on the infiltration of cells inside the 3D PLLA scaffolds [247]. Figure 16
contains representative cross-sectional images of PLLA scaffolds cultured with BAECs, which have
been stained with 4′-6-diamidino-2phenylindole (DAPI) after 5 days of incubation. The cells were
cultured at the scaffold’s top surfaces. In case of the untreated scaffold surface, the density of the cells
was low and cell infiltration in the scaffold was very limited (Figure 16A). However, after Ar plasma
modification onsiderably more cells were prese t at the top surface of the scaffold and cell infiltr ti n
in the scaffold was higher (Figure 16B). As such, besides increasing c ll sprea ing and cell growth,
the Ar plasma treatment also promo e in vitro cell infiltrati n in the scaffold. It is most likely that
the scaffold was homoge ously modified by th Ar plasma treatment due the high scaffold porosity,
which can, in turn, explain the increased cell infiltration in the Ar plasma-treated scaffold. The authors
also conducted in vivo experiments by implanting the scaffolds under the skin of Sprague-Dawley rats.
The obtained results revealed that the Ar plasma treatment was also able to improve the PLLA scaffold
bioactivity in vivo resulting in enhanced cell infiltration. However, additional scaffold modification
with bioactive molecules will still be required to improve angiogenesis, tissue-specific responses and
regeneration [247].
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is not destructive. As the authors envisioned skin TE applications for their scaffolds, they also examined 
the behavior of normal human epidermal keratinocytes (NHEK) and normal human epidermal 
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treatment time of 3 min was selected, although it is not clear whether this prolonged treatment time is 
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Figure 16. Cross-sectional images of (A) untreated and (B) Ar plasma-modified scaffolds sustained
after in vitro study with BAECs in the serum medium for five days. Top and bottom scaffold surfaces
are marked by dashed lines—reproduced with permission from [248]. Copyright Liebert, 2013.
Besides PCL and PLLA, also electrospun silk fibroin scaffolds have been exposed to a low-pressure
RF discharge gener t d in O2 [249]. Similar as for PCL and PLA scaffolds, the authors ob erved
a strong increase in surface hydrophilicity upon O2 plasma treatment: the WCA valu of the silk
fibroin scaffolds decreased from 115◦ to 39◦ after a 10 s plasma treatment, while a 30 s plasma
exposure resulted in a decrease in WCA to 0◦ due to rapid penetration of the water drop into the
nanofibrous structure. This increased wettability was also in the case of silk fibroin fully ascribed to
polar oxygen-containing group incorporation at the scaffold surface, as the nitrogen content remained
unaffected [249]. The auth r a so observed that the nanofiber morphology was not affected by the
performed plasma modification. However, no plasma exposure time was mentioned for the SEM image
used to prove this statement. Consequently, it is impossible to know at which plasma exposure times
exactly the plasma treatment is not destructive. As the authors envisioned skin TE applications for their
scaffolds, they also examined the behavior of normal human epidermal keratinocytes (NHEK) and
normal human epidermal fibroblasts (NHEF) on pristine and O2 plasma-treat d silk fibroin scaffolds.
For this purpose, a plasma treatment time of 3 min was s lected, although it is no clear whether this
prolonged treatment time is not resulting in nanofiber damage. The conducted cell assays revealed
that the initial number of adhered NHEF and NHEK cells was lower on the O2 plasma-exposed sample
compared to the untreated silk fibroin scaffold. In contrast, three days and seven days post-cell seeding,
the numbers of NHEF and NHEK cells proliferating on the plasma-treated scaffolds were significantly
higher compared to the untreated sample. The aut ors suggest d that this higher c llular activity was
caused by incre sed scaffold urface hydrophilicity.
Instead of an O2 plasma, Baek et al. have employed a microwave (MW)-induced plasma sustained
in Ar at atmospheric pressure to modify the surface properties of a nanofibrous silk fibroin 3D scaffold,
obtained by electrospinning followed by salt leaching [249]. The plasma exposure time was fixed
at approximately 12 s in this specific work. Although limited attention was paid to the scaffold
surface characterization, an extended examination of the cellular behavior of neonatal human knee
articular chondrocytes (nHAC-kn) was performed. The authors observed that the attachment and
proliferation of the chondrocytes was significantly increased on the plasma-modified scaffolds, except
for a one-day post-cell seeding. Additionally, they also examined the morphology of the nHACs
growing on the scaffolds seven days post-seeding using SEM. The cells on the pristine scaffold spread
only locally on the surface, as shown in Figure 17A. In contrast, the cells on the plasma-treated
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scaffolds almost fully covered the scaffold surface, while maintaining the natural original morphology
of articular chondrocytes (Figure 17B). Based on these obtained results, the authors suggested that the
plasma-modified scaffolds can be potentially used as cartilage TE scaffolds.
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Instead of using pure oxygen for surface activation, air plasma, which is less expensive, can be
just as effective. Two separate studies conducted by De Valence et al. [250] and Prabhakaran et al. [251]
focused on a vacuum RF plasma sustained in air and operating at 30 W power for the surface activation
of PCL scaffolds. Both papers reported a decrease in WCA from 122◦ to 0◦ upon a 1 min air plasma
treatment. Although air is mainly consisting of nitrogen, the performed plasma treatments were found
to result in a negligible incorporation of nitrogen on the surface of electrospun PCL scaffolds. However,
a significant incorporation of oxygen was observed (increase of 4–12%), which is considered to be the
main responsible for the highly increased surface wettability. Unfortunately, the air plasma treatment
was also found to have a negative effect on the tensile strength of the PCL scaffolds, while the elongation
at break remained unaffected [251]. De Valence et al. also examined the growth of Rhomboid smooth
muscle cells on control and air plasma-treated PCL scaffolds, but observed no statistically significant
improvements in cell adhesion and proliferation upon plas a treatment. Nevertheless, the cells
were found to have a more spread-out morphology in comparison to the untreated electrospun PCL
scaffold [250]. In contrast, Prabh karan et al. [251] showed a significa tly improve prolif ration of
Sc wann cells by conducting an air pla ma treatment on lectrospun PCL scaffolds. These resul s thus
show tha cell-surface interactions are not only depending on the applied plasma treatment, but also
on the cell type ich is bei g investigat d.
Similar to what was done by Cheng et al. on PLLA scaffolds [247], De Valence et al. also compared
the in vivo performance of pristine and air plasma-modified tubular PCL scaffolds [250]. In a first step,
both scaffold types were subcutaneously implanted into Sprague-Dawley rats and after three weeks,
the implants and the surrounding tissues were removed from the rats. In the next step, the implants
were fixated and embedded in paraffin, after which the middle of the implant was cut into sections in
the transversal direction (thickness of 4 µm). These 4 µm thick sections were subsequently stained
with hematoxylin-eosin (H&E) and scanned at a high resolution. After three weeks of subcutaneous
implantation, it was observed that the lumens of both untreated and plasma-treated implants towards
the center of the tubes were still void of tissue, resulting in cell infiltration only from the outer side.
At the tissue-scaffold interface in the case of both scaffold types, a thin and continuous layer of large
cells was observed. Moreover, for both implants, no large inflammatory responses and no thick fibrin
capsules around the scaffolds were observed. Moreover, a thick layer of cells, including fibroblasts,
macrophages, some neo-capillaries and scarce lymphocytes infiltrated both scaffolds from the outside.
However, this infiltrated cell layer presented a considerably larger penetration depth, makes out a larger
area of the total scaffold wall and has a significantly higher cell density in case of the plasma-treated
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scaffold compared to the untreated sample, both in terms of depth of penetration depth and of area
fraction of the total scaffold wall. Besides subcutaneous implantation, the pristine and plasma-modified
tubular PCL scaffolds were also implanted in the abdominal aorta of rats to act as vascular TE
scaffolds. After three weeks of implantation, the vascular implants were extracted, fixed, cut in the
longitudinal direction, fixed in paraffin and cut into 4 µm thick sections which were also stained with
H&E and scanned at high resolution. In Figure 18, the untreated and air plasma-modified vascular
scaffolds after H&E staining are depicted together with the quantitative results of the cellularized
area and the capillaries per field of view. For both scaffolds under study, cell movement from the
adventitia toward the scaffold wall assisted in the formation of a neo-tissue, but this formation was
more pronounced in the case of the plasma-modified scaffold (Figure 18A,B). In addition, a similar
cellular infiltrate as observed on the subcutaneous implants, was also seen. At the adventitial edges
of the scaffolds, a continuous lining of large cells was observed for both scaffold types and a dense
infiltrate of fibroblasts, macrophages, neo-capillaries and some lymphocytes invaded the scaffolds from
the adventitia. Quantification of this infiltrate (Figure 18C) showed that the average cell penetration
depth was considerably enhanced by the performed plasma modification process. The authors also
performed quantification of the neo-vascularization (Figure 18D) and observed a significant increase in
capillaries per field of view in the case of the plasma-treated PCL tubular scaffold. In addition to the
dense cell infiltrate, isolated fibroblasts and lymphocytes could also be found throughout the thickness
of both scaffold types, while no transanastomotic migration of smooth muscle cells into the synthetic
scaffolds was observed. It was therefore concluded that the conducted air plasma treatment prompted
the formation of the neo-tissue and accelerated the tissue regeneration process. Plasma modification
was therefore considered by the authors as a simple and effective method to improve the performance
of TE scaffolds in vascular applications.
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Besides O2, Ar and air plasmas, which are known to result in the introduction of oxygen functional
groups, also nitrogen-containing plasmas (N2, NH3, He/NH3 . . . ) can be employed for the surface
activation of nanofibrous TE scaffolds. Different authors have already focused on examining the
impact of a nitrogen (N2) plasma on the surface characteristics and cellular interactions of electrospun
scaffolds [180,252–255]. In 2014, Dolci et al. [252] employed a linear corona discharge sustained in N2
at atmospheric pressure to modify the surface properties of electrospun PLLA scaffolds [256]. Plasma
treatments were performed in the open air and plasma exposure time was fixed at 20 s. The performed
plasma treatment did not induce modifications to the morphology, the thermal characteristics and the
mechanical properties of the PLLA scaffolds. The only appreciable effect of the N2 plasma treatment
was a slight decrease in the elastic modulus associated with a small increase of deformation at break,
attributed to a slight loss of rigidity. Similar to O2 plasmas, the N2 plasma treatment drastically lowered
the WCA value of the PLLA scaffolds from 120◦ for the pristine sample to values close to 0◦ (as the
water drop instantaneously penetrated into the scaffold) for the plasma-treated mesh. According to
the authors, the enhanced PLLA surface hydrophilicity is due to the introduction of oxygen-containing
functionalities on the scaffold surface, although XPS measurements are not included to prove this
statement. The authors did, however, detect a higher content of oxygen-containing groups (namely
COOH groups) on N2 plasma-treated PLLA scaffolds through chemical conjugation reactions followed
by functionalization with the fluorescent fluorescein isothiocyanate molecule. This peculiar oxygen
incorporation can be explained by the fact that the N2 plasma treatment in this work is conducted in
open air. Consequently, it is reasonable to assume that air entrainment in the plasma region causes
the formation of highly reactive oxygen species responsible for the introduction of oxygen-containing
functionalities at the material surface. In the final stage of their research, Dolci et al. also compared
the behavior of mouse embryonic fibroblasts (MEFs) on untreated and N2 plasma-modified PLLA
scaffolds [256]. MEFs cultured on the plasma-modified scaffold showed a more elongated and dendritic
morphology and a higher vitality than MEFs cultured on the untreated scaffold.
More recently, Asadian et al. have examined the surface activation of PCL and chitosan
(CS)/polyethylene oxide (PEO) scaffolds using a medium pressure DBD sustained in nitrogen [180,253].
In contrast to the work of Dolci et al. [256], N2 plasma treatments of the scaffolds were thus performed
in a closed chamber. For both scaffold types, the discharge power was fixed at 4.6 W and the plasma
exposure time was varied between 5 and 60/70 s for the CS/PEO and PCL scaffolds respectively. In case
of PCL, the WCA value was found to decrease from 135◦ to 25◦, while for the more hydrophilic CS/PEO
scaffolds, the WCA decreased from 57◦ to approximately 15◦. The applied N2 plasma treatments also
caused no morphological changes to the PCL and CS/PEO scaffolds. XPS analysis revealed that besides
the O/C ratio, also the N/C ratio was significantly increased on the plasma-modified CS/PEO scaffolds,
showing that both oxygen- and nitrogen-containing functionalities were introduced on the CS/PEO
scaffolds’ surfaces. In contrast, in case of PCL scaffolds, only the introduction of nitrogen-containing
functionalities was observed. XPS derivatization reactions also revealed that the N2 plasma treatments
only resulted in a low incorporation of primary amine (NH2) groups. The authors also examined
the behavior of HFFs on pristine and N2 plasma-modified PCL and CS/PEO scaffolds and observed
significantly better HFF attachment and proliferation on the plasma-modified samples.
As different studies have observed superior cell growth on NH2-enriched surfaces in comparison
to other functionalized surfaces [255,257], efforts have also been undertaken to specifically graft NH2
functional groups using NTPs on nanofibrous TE scaffolds. For this purpose, plasmas sustained in
ammonia (NH3) have been commonly applied, although also in this case only a small percentage
of nitrogen is generally incorporated as NH2 groups. In a recent study, Ivanova et al. [244] have
exposed PCL scaffolds to a vacuum RF discharge sustained in NH3 using a discharge power of 50 W
(plasma exposure time: 120 s). In this case, the WCA was found to only decrease with 20◦, which
was significantly lower compared to the ones observed when they applied Ar and O2 plasmas to the
same PCL scaffolds (50◦ and 90◦ respectively). XPS analyses also revealed that the conducted NH3
plasma modification resulted in a slight reduction in oxygen content combined with only a low amount
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of nitrogen incorporation. Unfortunately, no specific information was provided on the amount of
NH2 groups that were incorporated on the PCL nanofibrous surface. The low introduction of polar
functionalities can, however, explain the rather poor increase in surface hydrophilicity of the PCL
scaffolds upon NH3 plasma treatment. The authors also concluded that an O2 plasma seems to be
the most efficient in increasing the PCL surface hydrophilicity as this plasma results in the highest
incorporation of oxygen functional groups.
NH3 plasma treatments have also been applied to PLGA nanofibrous scaffolds by Park et
al. [258,259]. In 2007, Park et al. examined the effects of a low-pressure NH3 discharge on PLGA
nanofibers and also used the same plasma set-up sustained in O2 to modify the surface properties of
the PLGA nanofibers. Plasma exposure times were varied between 30 and 300 s. Unfortunately, no
information on applied discharge powers could be found in the publication. When exposed to the
NH3 and O2 plasmas for 30 s, no significant changes in the morphology of the PLGA nanofibers were
observed. With increasing plasma exposure times up to 300 s, the dimensions and morphology of the
PLG nanofibers remained unaffected when applying the NH3 plasma treatment. In contrast, PLGA
nanofibers exposed to O2 plasma for 300 s slightly lost their nanofibrous structure. This observation
could suggest that an O2 plasma is more destructive than an NH3 plasma, however, as no information
is given on the applied discharge power, the observed differences in damage may also be attributed
to the use of a higher discharge power in case of O2 plasma. To investigate changes in surface
hydrophilicity, the WCA evolution as a function of plasma exposure time was also obtained using both
discharge gases (NH3 and O2). In contrast to the work of Ivanova et al. [244], the ammonia plasma
most effectively enhanced the surface hydrophilicity of the PLGA nanofibers: the WCA of the PLGA
nanofibers decreased from 134◦ to 115◦ and 45◦ after a 300 s treatment with O2 plasma and NH3 plasma
respectively. XPS analysis also found that the O2 plasma treatment resulted in the incorporation of
oxygen functional groups, while in the case of NH3 plasma treatment, up to 3 at % of nitrogen was
grafted to the PLGA nanofibers. Unfortunately, information on the amount of incorporated NH2 groups
was again not given. The authors also examined the adhesion and proliferation of 3T3 fibroblasts on
the O2 and NH3 plasma-treated PLGA samples using an MTS assay and the results they obtained
are shown in Figure 19. Cellular adhesion to PLGA was significantly improved by plasma treatment,
especially when using the NH3 plasma treatment. Additionally, cells seeded on NH3 plasma-treated
nanofibers proliferated significantly more than those on untreated or O2 plasma-treated nanofibers, as
can be clearly seen in Figure 19. This enhanced cell growth upon NH3 plasma modification may be
attributed to the more hydrophilic surface properties of the NH3 plasma-treated PLGA nanofibers.
In an additional paper, Park et al. more closely examined the influence of plasma exposure time
on the cellular behavior of 3T3 fibroblasts on NH3 plasma-treated PLGA scaffolds using the same
plasma reactor as mentioned above [259]. However, in this case, the applied discharge power was
mentioned to be 100 W and the plasma exposure time was set to 30 s, 60 s, and 180 s. Interestingly, the
authors observed that prolonged plasma treatment times resulted in reduced cell viability, however, a
clear explanation for this peculiar behavior was not given [259].
Finally, Cheng et al. also exposed PLLA microfibrous scaffolds to a vacuum RF plasma reactor
(type CCP) using an optimized NH3 plasma treatment [247]. In a first step, an NH3 plasma treatment
was conducted for 5 min at 50 W using a mixture of Ar and NH3, after which a 30 s H2 plasma treatment
at 10 W was performed to maximize the amount of incorporated NH2 groups at the scaffold surface.
Hereafter, this modification procedure will be attributed to Ar-NH3/H2 treatment. These authors
also conducted a pure Ar plasma treatment on the same microfibrous PLLA scaffolds, as extensively
described previously. Upon Ar-NH3/H2 plasma treatment, the WCA value of the PLLA scaffolds
was found to be considerably lower than in the case of Ar plasma treatment as WCA values close
to 0◦ were observed. XPS analysis revealed the incorporation of nitrogen groups on the Ar-NH3/H2
plasma-treated scaffolds and the amount of incorporated NH2 groups were also quantified (NH2/C ratio
equal to approximately 1.5%). Cell studies revealed that BAECs and BSMCs adhered and elongated
more on the Ar-NH3/H2 plasma-treated scaffold than on the Ar plasma-treated sample. In contrast,
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the applied Ar plasma modification was more efficient in improving the growth rate of both BAECs
and BSMCs than the Ar-NH3/H2 plasma modification. A possible reason for the various proliferation
rates after these plasma treatments is that the surface chemical functionalities introduced by the Ar
plasma not only improved wettability but also caused serum protein adsorption in a way which is
more desirable for cell growth, despite the fact that the Ar-NH3/H2 plasma treatment resulted in a
higher initial cell spreading. It seemed that Ar surface activation was more favorable to enhance cell
proliferation than surface functionalization with −NH2 groups, which is widely known to improve
surface biocompatibility. Obviously, more studies are needed to completely understand the influence
of these plasma conditions on the biochemical characteristics of PLLA scaffolds.
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A summary of all conducted in vitro cell studies on plasma-activated nanofibrous scaffolds can be
found in Table 7, arranged according to the envisioned TE application.
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Table 7. Summary of in vitro cell studies performed on plasma-activated nanofibrous scaffolds.




stem cells (iPSCs) MW O2 Polyethersulfone (PES) Enhanced proliferation and osteogenesis [261]
Human primary





PCL Improved cell attachment andproliferation [208]
MC3T3 RF O2 PCL Improved cell adhesion and ALP activity [246]
Human mesenchymal stem
cells (hMSCs) Not specified Ar and N2 PCL
Improved cell attachmentAccelerated
differentiation towards osteoblasts [262]
hMSCs Not specified He PCL/CMC
Enhanced osteoinductivity without
external osteogenic differential agent, did
not support the proliferation
[263]
hMSCs RF O2 PolyActive
Significant upregulation of bone
sialoprotein and osteonectin expression [211]
hMSCs Not specified Air PLGA
Greatly enhances peptide immobilization
which increases the ALP activity, calcium
content and expression osteogenic
markers of collagen type-I, osteocalcin
(OC) and osteopontin (OP)
[264]
hMSCs RF O2 PLLA
Improved expression of genes associated
with osteoblast linkage [265]
hMSCs Not specified Air PLLA Improved cell proliferation, ALP activityand mineralization [266]













MW Ar Silk fibroin Improved cell attachment, proliferationand glycosaminoglycan synthesis [250]
Schwann cells (RT4-D6P2T) RF Air PCL Improved cell proliferation [258]
MSCs Not specified Air PCL
Improved cell attachment and
proliferation, chondro-differentiation in a
non-differential medium
[268]
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Table 7. Cont.
Cell Type Plasma Source Gas Substrate In Vitro Results Ref.
Mouse lung fibroblasts





PCL Improved cell adhesion and proliferation [180]
HFFs DBD Ar, N2 andHe/NH3










3T3 fibroblasts DBD O2 and NH3 PLGA Improved cell adhesion and proliferation






(MEFs) Corona N2 PLLA
More elongated and dendritic cell












cells (pMSCs) RF O2 PLLA Improved cell adhesion [250]
Adipose-derived stem cells
(ADSCs) DBD Ar and Air PCL
Improved cell adhesion, proliferation,




e Primary porcine smooth
muscle cells (SMCs) RF Air PCL Improved spread-out cell morphology [250]













Human monocyte RF Air PLLA
Disruption of macrophage polarization
balance towards an anti-inflammatory
profileImproved cell morphology with
filopodia-like and podosome-like
structures on plasma-treated samples
[270]
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4.3. Protein Immobilization or Adsorption on Plasma-Activated Nanofibrous Scaffolds
It has already been observed that preliminary protein adsorption upon initial exposure of
nanofibers to media culture (called protein corona) highly depends on the nanofiber surface chemical
cues. This protein corona behavior is highly able to control the cell fate by altering/initiating intra- and
inter-cellular signaling pathways [180,254]. In an effort to more precisely control cellular interactions,
a large number of proteins have already been covalently immobilized on plasma-activated nanofibrous
scaffolds using carbodiimide coupling of a carboxylic (COOH) group with an NH2 group, [242,250,271].
Depending on the immobilization conditions, this strategy typically has a minimal effect on the
conformation of the protein structure, meaning that it is possible to retain the functional efficiency
of the immobilized proteins. Through tailored protein immobilization, more specific desired cellular
responses can be achieved [272,273] compared to just plasma-activated nanofibrous scaffolds, making
this a very popular approach to functionalize TE scaffolds. In contrast to covalent immobilization,
a dip coating procedure can also be used in which proteins are physically adsorbed on nanofibrous
scaffolds [274,275].
Among different proteins, which can be immobilized or adsorbed on plasma-activated
nanofibrous scaffolds, collagen is by far the most widely examined [135,250,276–278]. In an
effort to develop an ideal bone graft substitute, Shabani et al. grafted collagen I onto the
surface of a plasma-activated polyethersulpone (PES) nanofibrous scaffold to promote the scaffold
osteoconductivity [272], since the pristine polymer shows a low cell affinity for cell infiltration.
In this particular work, plasma modification of the PES scaffold was carried out in pure O2
using a low-pressure discharge for 5 min. Subsequently, collagen I was covalently bond to the
plasma-activated surface using a 2 step process: first, the plasma-treated samples were immersed
in a 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide/N-hydroxysuccinimide (EDC/NHS) solution
(5 mg/mL) for 12 h, after which they were subsequently immersed in a 1 mg/mL collagen I solution
overnight. WCA analysis showed that the O2 plasma treatment resulted in a decrease in WCA
value from 132◦ to 0◦, while after collagen grafting the WCA value remained at 0◦. Morphology
results also revealed that the average fiber diameter and porosity of the PES scaffolds were not
affected by the O2 plasma treatment. In contrast, after collagen grafting, which was confirmed using
Fourier-transform infrared spectroscopy (FTIR), a small decrease in porosity and an increase in average
fiber diameter could be observed. The authors also compared the behavior of unrestricted somatic
stem cells (USSCs) on the untreated, plasma-modified and collagen-grafted PES scaffolds and observed
the following: (1) the USSCs proliferated significantly better on the collagen-grafted scaffolds, (2)
collagen-grafted scaffolds had the highest capacity to support osteogenic differentiation of the USSCs,
which was confirmed via the assessment of osteogenic markers and (3) USSCs infiltrated best into
the collagen-grafted scaffolds as evidenced from histologic examination. Consequently, the authors
concluded that collagen-grafted PES scaffolds can be suitable for potential 3D bone grafts with high
capacity for bone healing and regeneration in vivo. Additionally, also mouse embryonic stem cells
(mESCs) cultured on the collagen-coated PES scaffolds were found to have a typical undifferentiated
morphology, enhanced proliferation, stable diploid normal karyotype and continued expression of
stemness and pluripotency-associated markers in comparison to the untreated PES scaffolds [279].
In another paper focusing on the covalent grafting of collagen on O2 plasma-treated PES scaffolds
written by Shabani et al. [278], a slightly different experimental procedure was used. In this particular
paper, a plasma treatment of 10 min instead of 5 min was applied as well as an immersion time of
6 h instead of 12 h in the EDC/NHS solution. Also in this paper, it was observed that USSCs showed
very high infiltration into the collagen-grafted scaffolds, as qualitatively observed from SEM imaging.
Exactly the same plasma-based strategy as the one first mentioned in this paragraph has been also
applied by Seyedjafari et al. to covalently graft collagen I on electrospun PLLA scaffolds [280]. In this
paper, the behavior of USSCs was also examined on untreated, plasma-modified and collagen-grafted
PLLA scaffolds and similar conclusions as mentioned for the PES scaffolds were drawn. Islami et al.
have also examined the covalent coupling of collagen I on plasma-activated PLLA scaffolds using
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carbodiimide chemistry showing excellent attachment, outgrowth and proliferation of CD 133+ cells
on the collagen-coated PLLA scaffolds [281].
Instead of using carbodiimide chemistry as was done in the papers described above to covalently
bind collagen to a nanofibrous surface, collagen can also be physically adsorbed on plasma-activated
surfaces. In 2010, Feng et al. carried out NH3 plasma treatments using a vacuum RF discharge (type
ICP) on random and aligned PLLA nanofibers after which the scaffolds were submerged into a collagen
I solution (300 µg/mL) in 0.1 M HCl at 4 ◦C for 12 h [242]. At a pH value of 7.2, the NH2 groups present
on the NH3 plasma-treated nanofibers displayed positive charges while the carboxyl groups of collagen
I displayed negative charges. Consequently, electrostatic interactions between these opposite charges
allow stable adsorption of collagen onto the aligned PLLA nanofibers. Blood outgrowth endothelial
cells (BOECs) cultured on the collagen-coated random and aligned PLLA nanofibers showed excellent
cell attachment and viability and maintained their endothelial phenotype. A similar strategy as the
one used by Feng et al. [242] was also followed by He et al. to physically adsorb collagen I on air
plasma-treated flat and tubular scaffolds fabricated from a 70:30 PLLA/PCL co-polymer [282,283].
The air plasma treatment was conducted using a vacuum RF discharge (type ICP) at 30 W for 5 min for
flat random and aligned scaffolds and 15 min for the tubular scaffolds. These authors also observed
that the spreading, viability and attachment of human coronary artery endothelial cells (HCAECs)
was superior on the collagen-coated P(LLA-CL) flat scaffolds in comparison to the untreated scaffolds.
Moreover, it was also observed that the phenotype of the endothelial cells was also preserved on
these collagen-coated flat samples [283,284]. In case of the tubular nanofibrous P(LLA-CL) scaffolds,
HCAECs were also found to nicely elongate on the lumen of the scaffolds and these cells were observed
to achieve sub-confluency in only 1 day after cell culturing on the inside of the tubes. Additionally, after
a 10 day culture period, the phenotype of the HCAECs was still preserved and a thin layer of HCAECs
was covering the lumen of the conduits, as depicted in the images shown in Figure 20 [135]. From
all the above-mentioned results, it can thus be concluded that collagen-coated PLLA and P(LLA-CL)
nanofibers can be very suitable scaffolds for vascular TE applications.
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Figure 20. Visualization of the proliferation of HCAECs on plasma-modified tubular nanofibrous
P(LLA-CL) conduits 10 days after cell culturing: (A,B) SEM micrographs of the cell-seeded scaffolds:
(A) cross-section of the scaffold, (B) higher magnification image of the quadrangle shown in (A);
(C) cross-section of the scaffold after H&E staining and (D) cross-section of the scaffold after
immunostaining of PECAM-1. Original magnification: (A) 80×, (B) 2000×, (C) 200× and (D) 630×. Scale
bar: (A) 500 µm, (B,C) 2 mm and (D) 100 µm—reproduced with permission from [135]. Copyright
Wiley, 2009.
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Collagen I has also been physically adsorbed on the surface of nanofibrous poly
(hydroxybutyrate-co-hydroxyvalerate) (PHBV) scaffolds by Ai et al. [285] and Rezaei-Tavirani et al. [284]
to improve its cell affinity as this polymer is a hydrophobic polyester possessing poor cellular
interactions. After applying an MW plasma sustained in O2 for 30 or 60 s at a power of 100 W, the
plasma-activated scaffolds were submerged in a collagen I solution (15 mg/mL in 50 mM acetic acid)
for 2 h at 50 ◦C. WCA analysis showed that the performed plasma treatments resulted in an increased
PHBV surface wettability as the WCA was found to decrease from 67◦ to approximately 56–58◦ after
plasma treatment. Cellular investigations using USSCs also revealed better cell adhesion, growth
and cell viability on the collagen-coated PHBV nanofibers compared to their untreated counterparts,
showing that even minor changes in wettability can have a profound impact on cell-surface interactions.
After collagen grafting, laminin immobilization is the second most investigated protein that
has been grafted on plasma-activated nanofibrous scaffolds. In 2008, Koh et al. have examined in
detail the grafting of laminin on nanofibrous PLLA scaffolds after performing a vacuum RF plasma
treatment in air (30 W, 5 min) [285]. Two approaches were used to graft laminin on the plasma-treated
PLLA scaffolds: (1) covalent immobilization of laminin using carbodiimide chemistry and (2) physical
adsorption of laminin by immersing the plasma-activated samples into a laminin solution. The authors
observed a homogeneous distribution of laminin on the PLLA nanofibers for both applied grafting
strategies and showed that for each approach, laminin was added to the surface of the PLLA scaffold
as indicated by the presence of a nitrogen peak in the XPS survey spectra. The behavior of nerve PC12
cells on the differently prepared PLLA scaffolds was also examined by the authors and it was observed
that the laminin-PLLA nanofibers showed better cell viability compared to the unmodified PLLA
sample. Additionally, the laminin-modified scaffolds also supported the attachment and proliferation
of PC12 cells and can thus serve as effective substrates to enhance nerve regeneration. Moreover, it
has been found that silk fibroin (SF) shows great potential for TE applications, however, this material
has a limited cell affinity due to the lack of cell recognition sites. As such, laminin has also been
physically adsorbed on O2 plasma-treated SF/PEO scaffolds envisioning nerve TE applications by
Rajabi et al. [272]. The absorbance level of dissolved formazan (MTS assay) was measured as an
indication of the proliferation of Schwann cells seeded on tissue culture polystyrene (TCPS), untreated
SF/PEO nanofibrous scaffolds and laminin-functionalized SF/PEO nanofibrous scaffolds and the results
are shown in Figure 21. As it is shown, cell viability and proliferation were not statistically different on
day 1 and day 3 for all investigated sample conditions. Only after five days of incubation, the number
of cells was found to be significantly increased compared to the earlier examined days. Figure 21 also
reveals that the Schwann cells proliferated better on the untreated SF/PEO scaffolds compared to TCPS,
while the best cell proliferation was observed on the laminin-functionalized scaffolds, especially after
a five-day culture. Consequently, Rajabi et al. [272] came to the same conclusion as Koh et al. [285],
namely that laminin-coated scaffolds can be excellent candidates for nerve TE applications.
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nanofibrous scaffolds [271]. In a study written by Wang et al., electrospun silk fibroin scaffolds were 
first exposed to a low-pressure Ar plasma, after which the anti-coagulant heparin was grafted to the 
plasma-activated scaffolds by immersing the samples in a 5 mg/mL heparin sodium salt aqueous 
solution for 30 min [271]. This strategy was followed in an effort to improve the anti-coagulative 
properties and biocompatibility of the scaffolds. Results clearly showed that without the use of a 
plasma pre-treatment, only a few heparin particles were seen on the scaffolds. On the contrary, on 
the Ar plasma-treated silk fibroin scaffolds (90 W, 5 min), a significant mass of heparin particles, 
which were homogeneously distributed along the scaffold, was present. Moreover, even after 
washing the scaffolds in an ultrasonic water bath, most of the heparin particles remained on the 
plasma-treated scaffold surface indicating strong interactions between the scaffold surface functional 
groups and the heparin granules. The successful heparin grafting on the plasma-treated scaffolds was 
also further confirmed using FTIR and XPS analysis. As the plasma treatment time can also 
significantly affect the grafting efficiency, the authors also examined the heparin grafting efficiency 
as a function of Ar plasma treatment time and the obtained results are shown in Figure 22. This image 
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Figure 21. Proliferation of Schwann cells seeded on TCPS, electrospun silk fibroin (SF)/ polyethylene
oxide (PEO) nanofibrous scaffolds and electrospun laminin (LN)-functionalized SF/PEO nanofibrous
scaffolds at day 1, 3 and 5 (p < 0.01 (**), p < 0.005 (***) and p < 0.0001 (****)—reproduced with permission
from [270]. Copyright Wiley, 2018.
In a more recent study by Sahebalzamani et al., laminin has been physically adsorbed on CO2
plasma-treated electrospun PCL scaffolds [286]. The conducted plasma treatment led to a reduction
of the WCA value from 112◦ to 67◦ due to the introduction of oxygen-containing functionalities.
The subsequent dip coating in a laminin solution resulted in a further decrease in WCA value
down to 30◦. Similar as the previously mentioned studies, the adsorbed laminin was found to be
responsible for significantly improved fibroblast viability compared to the plasma-treated electrospun
PCL scaffold [286].
Besides laminin, also heparin has been physically adsorbed on the surface of plasma-activated
nanofibrous scaffolds [271]. In a study written by Wang et al., electrospun silk fibroin scaffolds were
first exposed to a low-pressure Ar plasma, after which the anti-coagulant heparin was grafted to the
plasma-activated scaffolds by immersing the samples in a 5 mg/mL heparin sodium salt aqueous
solution for 30 min [271]. This strategy was followed in an effort to improve the anti-coagulative
properties and biocompatibility of the scaffolds. Results clearly showed that without the use of a
plasma pre-treatment, only a few heparin particles were seen on the scaffolds. On the contrary, on the
Ar plasma-treated silk fibroin scaffolds (90 W, 5 min), a significant mass of heparin particles, which
were homogeneously distributed along the scaffold, was present. Moreover, even after washing the
scaffolds in an ultrasonic water bath, most of the heparin particles remained on the plasma-treated
scaffold surface indicating strong interactions between the scaffold surface functional groups and the
heparin granules. The successful heparin grafting on the plasma-treated scaffolds was also further
confirmed using FTIR and XPS analysis. As the plasma treatment time can also significantly affect the
grafting efficiency, the authors also examined the heparin grafting efficiency as a function of Ar plasma
treatment time and the obtained results are shown in Figure 22. This image clearly shows that the
heparin grafting efficiency gradually increases with increasing plasma exposure time until a maximum
value was observed at a plasma exposure time of 5 min. In contrast, a longer treatment time of 7 min
resulted in less efficient heparin grafting.
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time (* p < 0.05, significant different between the grafting efficiency of plasma-treated scaffolds and
untreated scaffolds; # p < 0.05, significant different between the performance at an Ar plasma exposure
time of 5 min compared to an Ar plasma exposure time of 1, 3 and 7 min)—reproduced with permission
from [273]. Copyright Elsevier, 2011.
In the second stage of their research, Wang et al. examined the in vitro antithrombogenicity
of the untreated and heparin-grafted silk fibroin scaffolds (Ar plasma: 90 W, 5 min) and observed
significantly enhanced anti-coagulative properties as a result of the heparin modification. Additionally,
L929 fibroblasts and vascular endothelial cells (VECs) were utilized to assess in vitro cell adhesion
and proliferation on the scaffolds before and after heparin grafting. It was observed that cells
adhered and proliferation much superior on the heparin-grafted scaffolds compared to the pristine
samples. Finally, the authors also examined the in vivo performance of their developed silk fibroin
scaffolds by implanting the scaffolds on the back of rats. It was observed that the scaffolds were
covered by regenerated tissue. In addition, the heparin grafted scaffold (Ar plasma: 90 W, 5 min)
showed considerably less inflammation and no rejection by the host as macrophages, neutrophils,
and lymphocytes were not seen. Electrospun heparin-grafted silk fibroin nanofibrous meshes are
thus excellent candidates for TE applications, including vascular grafts, wound dressings and skeletal
muscle substitutes.
Besides the above-mentioned proteins, a few research papers have also been focusing on the
grafting of elastin [287], gelatin [288,289], fibronectin [281] and soluble eggshell membrane protein [290]
on nanofibrous scaffolds. Also, in these cases, better cellular interactions were observed on the
protein-grafted scaffolds, consequently, the grafting of these less examined proteins will not be
described in detail in this review paper.
4.4. Grafting of Inorganic Particles on Plasma-Activated Nanofibrous Scaffolds
Incorporating inorganic particles in nanofibrous scaffolds and deposition of a thin inorganic layer
on a scaffold surface to obtain excellent performance in bone tissue regeneration are highly promising
ways for biomineralization of the scaffold bulk or scaffold surface respectively. Different inorganic
molecules have already been utilized for this purpose, including hydroxyapatite (HA), CaCO3 and
TiO2 [291–294]. The deposition of the previously mentioned species on as-fabricated electrospun
scaffolds has already been widely examined. However, very recently, research is also been conducted
on the deposition of these species on plasma-activated nanofibrous scaffolds [244,295].
Ivanova et al. [244] have examined in detail the enrichment of PCL nanofibrous scaffolds with
CaCO3 on untreated and different plasma-treated samples. After performing plasma activation
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experiments in O2, NH3 and Ar atmospheres, the scaffolds were immersed in a CaCl2 solution,
followed by the addition of a Na2CO3 solution to the system. This wet precipitation method was found
to result in the crystallization of CaCO3 particles on the PCL scaffolds. SEM images of the differently
prepared CaCO3-enriched PCL nanofibrous scaffolds can be found in Figure 23. As shown in this
figure, there are clearly visible differences in the granule dispersion and CaCO3 coating homogeneity
on the different PCL scaffolds under study. For the untreated and Ar plasma-exposed PCL sample,
multiple CaCO3 agglomerates can be seen on top of the nanofiber surfaces (the areas inside the circles in
Figure 23). In contrast, in the case of the deposited coating layer on the O2 plasma-treated PCL scaffold,
a rather smooth and uniform surface was noticed. For this sample, the CaCO3 coated layer consisted
of agglomerates of spherical porous CaCO3 microparticles attributed to be vaterite (white arrows in
Figure 23). In contrast, for the NH3 plasma-treated sample, the coating contains cubic CaCO3 particles
(black arrows in Figure 23), indicative of the calcite phase. These differences in coating morphology
and phase composition were explained by the authors by the different surface composition of the
plasma-modified PCL scaffolds. The involved researchers presumed that the O2 plasma treatment
resulted in the production of a large number of active growth sites for the nucleation of vaterite
granules, which lead to a more homogeneous and uniform coating morphology than obtained with the
Ar and NH3 plasma modifications. In contrast, after NH3 plasma treatment, the PCL surface becomes
saturated with amino groups, which induces the crystallization of CaCO3 into calcite. Based on their
results, the authors concluded that the CaCO3 enriched O2 plasma-treated PCL scaffold shows the
highest potential for bone TE applications.
Besides CaCO3, nanohydroxyapatite (n-HA) has also been coated onto the surface of
plasma-activated nanofibrous scaffolds for bone TE purposes. Seyedjafari et al. [296] have focused
on this particular topic and have examined the capacity of their fabricated PLLA scaffolds for
bone formation in vitro using USSCs under osteogenic induction and in vivo after subcutaneous
transplantation in mice. In a first step, the authors performed an O2 plasma treatment for 5 min
on electrospun PLLA scaffolds, after which the samples were immersed in a 1% (w/v) solution of
n-HA in deionized water. Based on SEM imaging and an MTT assay, the authors concluded that
the plasma-treated and n-HA-coated PLLA scaffolds were observed to support adhesion, elongation
and proliferation of USSCs. During osteogenic differentiation, remarkably higher levels of alkaline
phosphatase (ALP) activity (a major osteogenic marker), biomineralization and bone-linked gene
expression were seen on n-HA/PLLA in comparison with plasma-treated PLLA scaffolds. Interestingly,
the coating of n-HA on the surface of electrospun PLLA nanofibers was also found effective for bone
formation within 10 weeks after subcutaneous implantation, which was not the case when using
plasma-activated PLLA scaffolds. Consequently, the authors suggested that the n-HA directly coated
on the surface of nanofibers can induce ectopic bone formation in vivo in the absence of exogenous
inductive agents or cells [297].
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4.5. Plasma Polymerization
Besides plasma activation, which is by far the most commonly applied plasma-based method to
nanofibrous TE scaffolds, some authors have also conducted plasma polymerization experi ents on
electrospun nanofibers [297–301]. In this case, monomer molecules in the vapor phase (typically carried
by an inert gas flow) are introduced in the active plasma region. Precursor activation/fragmentation
will then occur in the plasma discharge due to interactions between the active plasma species and
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the precursor molecules. These reactive precursor fragments can, in turn, recombine into higher
molecular weight compounds (so-called plasma polymers) either on the sample surface or in the active
plasma zone before condensing onto the sample surface. It is also noteworthy to mention that plasma
polymerization can occur with multiple monomers in the vapor phase, even if they do not contain
unsaturated bonds or cyclic structures [232,299,300]. The mechanism of plasma polymerization has
already been well-described in specific reviews on this topic and will therefore not be discussed further
here [301,302].
In 2014, Safoji et al. [298] were one of the first to use a plasma polymerization approach on
electrospun nanofibrous scaffolds envisioning TE applications. These authors exposed polyethylene
terephthalate (PET) nanofibers to a low-pressure RF discharge (type CCP) sustained in a mixture of
ethylene (C2H4) and NH3 using a mild plasma power of 10 W for a duration of 15 min. These plasma
conditions were found to result in the deposition of an NH2-rich plasma-polymerized coating on the
surface of the electrospun scaffolds. SEM imaging also revealed that upon plasma polymerization,
the mean PET fiber diameter was only increased by 16 nm suggesting the deposition of only a very
thin NH2-rich coating on the PET nanofibers. Consequently, also the porosity of the nanofibrous
PET scaffolds did not significantly change after the plasma coating. The authors also compared the
behavior of human umbilical vein endothelial cells (HUVEC) on the untreated and plasma-coated
PET scaffolds and observed that the coating significantly improved the adhesion and growth of
HUVECs. Additionally, also the resistance of HUVECs to flow-induced shear stress was found to
be significantly improved by the plasma-polymerized coating. The properties of the plasma-coated
PET scaffold thus support the production of desired confluent HUVEC monolayers on the top surface,
contrary to conventional vascular grafts, where cells infiltrate inside the material. These plasma-coated
scaffolds are thus highly useful for the pre-endothelialization of the luminal side of small-diameter
vascular prostheses.
Instead of using a plasma sustained in a C2H4/NH3 mixture, Solovieva et al. [299] applied a
low-pressure RF discharge (type CCP) sustained in a mixture of Ar, C2H4, and CO2 to modify the
surface properties of PCL nanofibrous scaffolds. Using this approach, the authors were able to deposit
a COOH-rich coating, containing 0.57 at% of COOH groups, on the PCL samples. In the next step,
platelet-rich plasma (PRP) was physically adsorbed or covalently immobilized on the COOH-coated
PCL scaffolds. The authors examined the biocompatibility of the three types of PCL scaffolds under
study by investigating the adhesion, proliferation and viability of human mesenchymal stromal cells
(MSCs) on all sample types. Figure 24 shows fluorescent images of MSCs adhering to the differently
prepared PCL scaffolds after staining the actin filaments of the cytoskeleton with phalloidin (red)
and the cell nuclei with Hoechst 33342 (blue). This figure clearly shows that the MSCs seeded on
untreated PCL showed poor coloring of the cytoskeleton after 3 h. The cells were trying to attach to
the hydrophobic PCL surface, causing the creation of lamellipodia and actin-rich filopodia. However,
the lack of proper adhesion with the untreated PCL scaffold negatively influenced the survival and
proliferation of MSCs resulting in poor cell survival on untreated PCL after 72 h. On the COOH-coated
sample, the adhesion of MSCs was characterized by smaller spreading areas, but in contrast to the
untreated sample, the cells adhered better and showed a considerably distinct network of actin
filaments 72 h after cell seeding. Figure 24 also reveals that the best MSC adhesion was observed on
the PRP-coated samples: in this case, the MSCs showed an excellent spreading and multiple actin-rich
contact points with the surface as well as an obvious network of stress-fibrils.
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Cell proliferation and viability studies further revealed that the PRP-coated samples exhibited
superior levels of cell proliferation and cell viability. These enhanced cellular responses can be described
by the presence of a high amount of PRP fibronectin at the PCL scaffold surface, which is known to
strongly enhance cell adhesion, migration, and proliferation [296].
Very recently, Vozzi et al. have also examined the plasma polymerization of acrylic acid (CH2 =
CHCOOH) on a polyester urethane (PUR) scaffold mimicking cardiac tissue properties in an effort
to depo it a COOH-rich coating on nanofibrous samples [300]. A multi-step process wa pplied by
these authors: (1) Ar plasma activ tion for 1 min, (2) plasma polyme izatio using a plasma sustained
in acrylic acid vapor for 15 min and (3) covalent immobilization of fibronectin on the plasma-coated
scaffolds. The deposition of the coating and the protein immobilization were confirmed by FTIR and XPS
and the thickness of the deposited COOH-rich coating was found to be only a few nanometers. In the
next stage, primary rat neonatal cardiomyocytes were seeded on the fibronectin-functionalized scaffolds
and were found to show a high survival rate and a stable beating activity. The signal transduction
activity of these scaffolds was also examined and was found to be higher when the cardiomyocytes were
cultured on the fibronectin-coated sample compared to TCPS. Real-time polymerase chain reaction
analysis also showed a ignificant odulation at 14 days of card ac muscle and hyper oph -specific
genes i the fibr n ctin-functionalized PUR scaffolds, thereby confirming an inc pient process of
cardiomyocyte maturation [300]. A similar plasma-based strategy as mentioned above was followed
by Ko et al., in an effort to deposit COOH-rich coatings on PCL nanofibrous scaffolds [248]. XPS
analysis revealed the incorporation of oxygen-containing groups at the acrylic acid plasma-treated PCL
surfaces, however, no information is given on the specific number of COOH-groups. Additionally, the
mean PCL fiber diameter was also found to decrease upon acrylic acid plasma treatment suggesting
that instead of a plasma polymerization process, mainly nanofiber functionalization in combination
with etching occurred. The proliferation and differentiation of pre-osteoblast cells (MC3T3) were
also examined on the COOH-functionalized samples and compared with the cell behavior on O2
plasma-treated PCL scaffolds. MC3T3 adhesion and proliferation (up to 6 days after culturing) were
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found to be similarly increased for both applied plasma treatments compared to the untreated PCL
sample. However, the ALP activity, indicative of osteogenic differentiation, after 8 days of cell culture
was found to be higher on the acrylic acid-functionalized PCL scaffolds than on the O2 plasma-treated
PCL sample.
A final example of plasma polymerization experiments on nanofibrous scaffolds can be found in the
recently published paper written by Asadian et al. [301]. These authors have focused on the deposition
of a thiol (SH)-rich coating on electrospun PCL scaffolds by performing plasma polymerization
experiments using 1-propanethiol (CH3CH2CH2SH) as precursor monomer. A low-pressure RF
discharge (type ICP) was used with plasma exposure times varying between 5 and 60 s at a discharge
power of 100 W. Figure 25 shows the SEM images of untreated PCL nanofibers (A) and after a plasma
deposition time of 5, 10, 30 and 60 s in Figure 25B–E respectively. After a short deposition time of
5 s, the nanofibrous PCL morphology was noted to be quite close to the morphology of the untreated
PCL nanofibers. Additionally, the average PCL fiber diameter was slightly larger for this sample than
for the pristine PCL scaffold, evidencing the deposition of an approximately 15 nm thick coating on
the PCL nanofibers after 5 s. By carrying out a very short plasma polymerization step, it was thus
possible to keep the bio-mimicking nanomorphology of the PCL nanofibers. On the contrary, when
further increasing the plasma exposure time, considerable changes in the nanofibers’ morphology
were seen. At plasma exposure times ≥10 s, the coating was non-homogeneously deposited (higher
deposition on specific areas of the nanofibers) as can be found in Figure 25C–E. Moreover, the original
nanofibrous morphology of the untreated PCL nanofibers also gradually vanished by enhancing the
plasma exposure time as considerably thicker coatings were deposited in this case. Consequently,
the authors decided to use a pre-defined plasma polymerization time of 5 s for their remaining tests.
Upon plasma polymerization, the surface hydrophilicity was found to be largely unaffected, while
XPS analysis revealed the introduction of sulphur-containing groups at the PCL nanofiber surfaces.
The number of SH-functional groups was also quantified using XPS chemical derivatization and was
equal to 1.8 ± 0.5% when using a plasma exposure time of 5 s. In the final stage of their research,
the authors examined the in vitro adhesion and proliferation of bone marrow stem cells (BMSTs)
and observed superior MBST adhesion and proliferation on the thiol-coated samples compared to
pristine PCL.
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plasma polymerization step, it was thus possible to keep the bio-mimicking nanomorphology of the 
PCL nanofibers. On the contrary, when further increasing the plasma exposure time, considerable 
changes in the nanofibers’ morphology were seen. At plasma exposure times ≥10 s, the coating was 
non-homogeneously deposited (higher deposition on specific areas of the nanofibers) as can be found 
in Figure 25C–E. Moreover, the original nanofibrous morphology f the untreated PCL nanofibers 
also gradually vanished by nhancing the plasma exposure time as considerably thick r coat s 
were deposited in this case. Consequently, the authors decided to use a pr -defi ed plasma 
polymerization time of 5 s for their remaining tests. Upon plasma polymerization, the surface 
hydrophilicity was found to be largely unaffected, while XPS analysis revealed the introduction of 
sulphur-containing groups at the PCL nanofiber surfaces. The number of SH-functional groups was 
also quantified using XPS chemical derivatization and was equal to 1.8 ± 0.5% when using a plasma 
exposure time of 5 s. In the final stage of their research, the authors examined the in vitro adhesion 
and proliferation of bone marrow stem cells (BMSTs) and observed superior MBST adhesion and 
proliferation on the thiol-coated samples compared to pristine PCL. 
 
Figure 25. SEM images of PCL nanofibers before (A) and after 1-propanethiol plasma polymerization 
with a plasma exposure time of 5 s (B), 10 s (C), 30 s (D) and 60 s (E) (scale bars = 5 and 10 µm)—
reproduced with permission from [301]. Copyright Elsevier, 2019. 
Figure 25. SEM images of PCL nanofibers before ( ) a after 1-propanethiol plasma polymerization
with a plasma exposure time of 5 s (B), 10 s (C), 30 s (D) and 60 s (E) (scale bars = 5 and 10
µm)—reproduced with permission from [301]. Copyright Elsevier, 2019.
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As evidenced from the above paragraphs, only a few studies are currently published on the
deposition of plasma polymeric coatings on TE scaffolds, however, the results acquired in these studies
show great potential for plasma polymerization. As such, it is anticipated that more and more research
will emerge in the near future on the use of plasma polymerization approaches for TE applications.
5. Conclusions and Outlook
The main goal of this review was to give a comprehensive overview of the manufacturing strategies
(including thermally-induced phase separation, molecular self-assembly, and electrospinning) of
thermoplastic biodegradable nanofibrous scaffolds within the field of TE and the added value NTP
brings compared to other established techniques. The majority of the reviewed work focused on
the effects NTPs fueled by inert (Ar, He) and/or reactive (Air, O2, N2, NH3 . . . ) discharge gases
induced on the nanofiber scaffolds and their subsequent in-vitro performance. A variety of cell-types
(fibroblasts, osteoblasts, keratinocytes, stem cells . . . ) have been used to study the positive effects plasma
treatments had on cell-surface (adhesion, proliferation, and migration) and cell-protein interactions
(immobilization efficiency), for which potential applicability could be found in both hard (bone,
cartilage) and soft (skin, nerve, vein . . . ) TE. Despite plenty of positive and promising results, the
following concluding remarks should be made:
Almost all nanofibrous supports have a pseudo-2D geometry, a condition that stands far from
the actual structures required for TE. Reshaping nanofiber sheets is challenging, as they are easily
damaged, and they tend to charge when removed from the collector plate, resulting in spontaneous
folding. Some researchers have found ways to deposit them in a tubular fashion by adapting the
geometry of the collector plate, making them suitable for vein and nerve tissue regeneration. Still, the
highest potential lies in the combination of additive manufacturing technology with electrospinning,
a process that has emerged recently and is referred to in literature as direct writing electrospinning,
which allows for layer-by-layer deposition of electrospun bundles. In combination with NTP, it is
expected that this technology will continue to disrupt the current research lines and will lead to the
next generation of nanofibrous substrates for TE.
In most of the collected literature, notably little attention was given to the stability of the plasma
treatment during storage, despite the known fact that plasma-activated thermoplasts tend to lose
their treatment efficiency over time, a phenomenon known as aging or hydrophobic recovery. For
nanofibers, these aging phenomena are expected to be even more pronounced, as the active surface
area is orders of magnitude higher compared to non-porous surfaces. This susceptibility to aging
could prevent efficient water penetration into the fibrous structure, thereby negatively altering the
in-vitro performance.
Although plenty of data is available on possible effects of NTP on cell adhesion and proliferation,
very little information can be found on the induced effects on the metabolic activity of the seeded cells;
e.g., almost no studies are available that look at the impact of the plasma surface modifications on gene
expression. This sort of data is more readily available for other surface modification techniques and is
considered vital to understand the exact impact NTP can have on specific cell-surface interactivity.
Another surprising observation is the lack of in-vivo data of plasma modified nanofibrous
structures, even though for other types of scaffolds big discrepancies were described between
in-vitro and in-vivo performance. Without the necessary in-vivo studies, it seems that most of the
aforementioned studies will never surpass the label of “potentially useful” rather than finding their
way to the clinical level. Hopefully, this void in knowledge will be filled in the next few years, leading
to a selection of plasma-enhanced nanofibrous structures becoming available on the market.
Finally, the review paper also indicated that the use of plasma polymerization has not yet
widely spread within the nanofiber community, despite its many advantages over plasma activation:
higher functional group density, better stability over time and overall better in-vitro performance.
Although one has to be very careful in the selection of the plasma processing parameters to avoid fiber
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degradation/deformation and pore closure, it is expected that plasma coated nanofibers will inevitably
play a more prominent role in the near future.
These remarks clearly show that there still remains a lot of unexplored potentials and it seems that
many research groups are only now starting to realize the added value NTP brings to nanofiber-based
TE. It is therefore expected that in the future, the research volume dedicated to NTP-enhanced
nanofibers will only increase, hopefully leading to products that can have a positive impact on a
clinical level.
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